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Abstract: Dietary protein is critical for the maintenance of musculoskeletal health, where appropriate
intake (i.e., source, dose, timing) can mitigate declines in muscle and bone mass and/or function.
Animal-derived protein is a potent anabolic source due to rapid digestion and absorption kinetics
stimulating robust increases in muscle protein synthesis and promoting bone accretion and
maintenance. However, global concerns surrounding environmental sustainability has led to an
increasing interest in plant- and collagen-derived protein as alternative or adjunct dietary sources. This
is despite the lower anabolic profile of plant and collagen protein due to the inferior essential amino
acid profile (e.g., lower leucine content) and subordinate digestibility (versus animal). This review
evaluates the efficacy of animal-, plant- and collagen-derived proteins in isolation, and as protein
blends, for augmenting muscle and bone metabolism and health in the context of ageing, exercise
and energy restriction.
Keywords: animal-derived protein; plant-derived protein; collagen-derived protein; protein blends;
skeletal muscle; bone; ageing; exercise; energy restriction
1. Skeletal Muscle, Bone, Protein Sources and the Notion of Protein “Quality”
Dietary protein can attenuate skeletal muscle and bone decline during ageing [1,2] and energy
restriction [3,4] and can potentiate exercise-induced increases in muscle and bone mass and/or
function [5]. However, concerns regarding the sustainability of animal-derived proteins [6] has led to
an emerging interest in the efficacy of plant-derived and other (e.g., collagen-derived, blended) protein
sources for maintaining/optimising musculoskeletal health, which is currently a hotbed of research.
1.1. Definition of Animal, Plant, Collagen and Blended Dietary Protein Sources
From the outset, it is important that we define what is meant by animal, plant, collagen and
blended dietary proteins herein, to provide clarity and prevent misinterpretation. Animal-derived
refers to proteins directly originating from animal sources such as meat, fish, poultry, eggs and dairy
(and the constituents whey and casein protein) [7], which are also regarded as “complete” proteins
(i.e., they provide sufficient amounts of all essential amino acids (EAA) to meet human requirements) [8].
Plant-derived refers to proteins obtained from plant sources (e.g., wheat, soy) [9] and collagen-derived
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refers to proteins derived from gelatin and/or collagen hydrolysates [8,10]. Notably, gelatin/collagen
hydrolysates-derived proteins do originate from animal sources (e.g., bone, pigskin, fish skin [10]),
however, they are not regarded as “complete” proteins, hence our rationale for distinguishing them
from animal-derived protein sources for the purpose of this review. Finally, blended protein sources
refer to different sources/types of protein combined together to form one nutritional load.
1.2. Muscle and Bone Protein Turnover
In the simplest form, dietary protein can modulate muscle and bone health via the regulation
of muscle protein turnover [4,11] and bone matrix turnover and remodelling [12,13], respectively.
In regards to muscle, the global maintenance of skeletal muscle mass is governed by the dynamic
equilibrium between muscle protein synthesis (MPS) and muscle protein breakdown (MPB), where a
positive net muscle protein balance (i.e., MPS exceeds MPB) results in muscle growth and a negative
net muscle protein balance (i.e., MPB exceeds MPS) results in muscle loss [11]. Dietary protein provides
a critical source of amino acids (AA), which act as protein synthetic precursors and modulate anabolic
signalling activity, stimulating robust increases in MPS [9]. Further, protein-derived AA can attenuate
MPB, which is entirely attributable to insulin, contributing to a positive net protein balance [14].
In regard to bone, the cross-linking of collagen molecules involves the post-translation modification
of AA, therein requiring dietary-derived AA since many of the collagen fragments released during
breakdown cannot be re-utilised for bone matrix formation [15]. However, dietary protein can also
increase urinary calcium excretion, therein possibly increasing the risk of fractures or osteoporosis,
which has led to some controversy surrounding the efficacy of dietary protein for bone health [15].
1.3. Dietary Protein Requirements
The Recommended Daily Allowance (RDA) of dietary protein for adults (including older adults),
is currently 0.8 g/kg of high-quality protein per day [16], which is based on the minimum dietary
protein required to achieve nitrogen balance, thus maintaining body protein mass [17]. However,
short-comings associated with the nitrogen-balance technique have led to criticism and a call for the
protein RDA to be increased [17,18], particularly in the context of ageing, exercise, energy restriction
and disease, where protein anabolism and nitrogen excretion are affected [17–19]. Further, the current
RDA does not take into account the source of protein (i.e., animal, plant, collagen, blended), which is
an important consideration since there are known geographical differences in regard to the source of
protein intake. To highlight, western diets contain a higher proportion of total protein intake from
animal-derived compared to plant-derived protein sources [20,21]. Dietary analysis from the National
Health and Nutrition Examination Survey 2003–2006 study [21] indicated that 65% of protein intake in
US populations was from a combination of animal-derived sources, similar to the 66% reported in the
more recent (also US-based) PREMIER survey [20]. In comparison, African and Asian populations’
primary source of protein is plant-derived, at 77% and 66% of consumption, respectively [7]. Moreover,
in the western population, there is an apparent shift towards increased consumption of plant-derived
protein (in lieu of animal), due to perceived health benefits (e.g., reduced cardiovascular mortality [22])
and environmental sustainability [6]. Reflecting this shift, while the majority of prior research
investigations have focused upon characterising the effects of animal-derived proteins in relation to
musculoskeletal metabolism and health, there has been a recent surge of studies investigating the
influence of plant-derived (e.g., References [4,23–25]), collagen-derived (e.g., References [26–29]) and
blended (e.g., References [30–32]) protein sources.
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1.4. Protein Quality
The quality of a protein source is thought to be a central factor in its ability to provide a physiological
benefit, and is dependent upon the proportion of protein-derived AA from digestion and absorption
processes [7]. Protein quality is typically evaluated by the Protein Digestibility Corrected Amino Acid
Score (PDCAAS); however, the more recently introduced Digestible Indispensable Amino Acid Score
(DIAAS) allows for consideration of ileal AA digestibility, permitting a more accurate assessment
and indication of specific rate-limiting AA [33]. Thus, PDCAAS or DIAAS values theoretically afford
insight into protein requirements to maintain whole-body nitrogen and AA balance; however, crucially,
neither assessment discerns systemic or tissue-specific (i.e., musculoskeletal) impacts. For example,
while beef and soy protein have similar PDCAAS values (92 and 91, respectively [34]), ingestion of
4 oz of beef stimulates postprandial myofibrillar MPS responses to a greater degree than ingestion
of 4 oz of isonitrogenous soy protein [35]. Although, it should be considered that this may also be
due to differences in the macronutrient composition/food matrix (i.e., structure and interaction of feed
components [36,37]) of beef vs. soy protein. For a summary of animal- and plant-derived DIAAS and
PDCAAS scores, the readers are directed to the work of Burd et al. [37].
Therefore, the purpose of this narrative review is to consider the continually developing impacts
of animal- (Section 2), plant- (Section 3) and collagen-derived (Section 4) protein sources (incorporating
both acute and chronic study designs) in relation to skeletal muscle and bone metabolism and health.
Where sufficient data exists, this will be considered in the context of ageing [38], exercise [39] and
energy restriction [40], as conditions that negatively or positively affect musculoskeletal metabolism
and health. We will also address the emerging potential of protein blends as sustainable anabolic
sources for musculoskeletal health (Section 5) and finally, we will highlight future research directions
for each given context (Section 6). We would like to iterate that this is a narrative review, which includes
studies based on the suitability with the aforementioned criteria (i.e., animal and/or plant and/or
collagen feeding in the context of ageing, exercise, energy restriction on musculoskeletal outcomes).
Since we have not performed a systematic analysis, we would like to apologise to those authors who’s
work we may have unintentionally omitted from this review.
2. Animal-Derived Proteins: Effects in Relation to Age, Exercise, Energy Restriction and Source
2.1. Skeletal Muscle
The importance of dietary protein for skeletal muscle maintenance is undeniable. In young
healthy adults, animal-derived protein sources robustly increase acute MPS [41], which is entirely
attributable to the EAA content [42]. Of the EAA, the branched chain amino acids [43], and in particular,
leucine [14], provide the most potent anabolic stimulation. Further, protein-induced increases in
MPS are saturable and finite, with 20–40 g of animal-derived protein [41,44,45] (or 10–20 g EAA [46])
stimulating maximal MPS, which increases ~45–60 min following oral consumption (time taken for
digestion and absorption), reaching maximal stimulation (~two- to three-fold) between 1.5 and 3 h and
returning to baseline ~2–3 h post-consumption [39,47]. Interestingly, MPS levels return to baseline in
spite of continued muscle and plasma AA availability and elevated anabolic signalling [48], suggesting
that the muscle remains refractory to dietary protein-induced MPS stimulation for a currently unknown
period of time [39,47], which has been coined “muscle-full” [48].
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Given the utility of animal-derived protein intake in young healthy populations, a number of
large cohort studies have assessed the relationship between animal-derived protein intake and muscle
health across age. For example, in a study by Alexandrov et al. [49], muscle mass estimates from 24 h
urinary creatinine and analysis of food intake by questionnaires illustrated that increased intake of both
total protein and animal protein were associated with increased creatinine excretion (i.e., higher muscle
mass) in both young and older males and females. Similarly, data from the Framingham Offspring
Study found that higher protein intake from animal sources (e.g., red meat, poultry, fish) was associated
with a higher percentage muscle mass over a 9-year period in adults over the age of 50 years [1]. These
findings point towards positive effects of animal protein sources for the maintenance of muscle mass
across the lifespan.
With this in mind, determining the efficacy of animal-derived protein feeding for potentiating
muscle health in older adults has been a key aim of several investigations. Indeed, many studies
have demonstrated that dairy [50] and meat [41,51] protein sources stimulate MPS in older adults.
To demonstrate, one short-term study assessing the effects of a moderate (30 g) versus large (90 g)
serving of 90% lean beef on MPS in younger (~35 years) and older (~68 years) adults found that MPS
similarly increased in both age groups in response to the moderate serving of protein, with no further
increase seen with the larger serving in either young or older adults [41]. This data is suggestive of a
ceiling effect in healthy rested individuals in response to a single serving of animal protein, in line with
the aforementioned “muscle full” hypothesis [48]. Interestingly, this data (and others [51,52]) does not
support the notion of “anabolic resistance”, which states that ageing muscle displays attenuated protein
synthetic responses to protein feeding (and exercise) [53]. This is in disagreement with several studies
that have shown anabolic resistance in response to feeding with EAA [46,54] and animal-derived
protein [55]. To demonstrate, a retrospective cross-sectional study found that older adults exhibited
a blunted protein synthetic response following 20 g casein protein consumption, compared to their
younger counterparts [55]. This particular study pooled multiple well-controlled trials with similar
study designs, thereby accruing a large volunteer pool (compared to other similar studies), and thus
provides strong evidence to support the existence of anabolic resistance in ageing [9,55]. Although the
mechanisms underlying anabolic resistance remain to be fully elucidated, a suggested contributor is the
rate of protein digestion and AA absorption, which may impact the postprandial availability of AA for
MPS [9,56], whereby compared to slowly digestible proteins, more rapidly digestible proteins result in a
greater postprandial stimulation of MPS [57]. Whilst it has been shown on multiple occasions that older
adults ingesting 20 g whey protein increased MPS to a greater extent than those ingesting 20 g casein
protein (which has slower digestion and absorption properties compared to whey protein), leucine
content was higher in whey protein, which is more likely the key anabolic driver [58,59]. Additionally,
pulse feeding, which results in lower and more gradual aminoacidemia and leucinemia compared to
bolus feeding, elicited equivalent net muscle anabolism in older adults (compared to bolus), suggesting
that the speed of digestibility does not affect MPS [60]. The matrix and texture of the feed, which can
be a consequence of food processing (e.g., mechanical processing such as mincing [57]), is another
factor modulating the digestion and absorption and thus, potentially the protein synthetic response to
animal-derived protein [57]. To highlight, Pennings et al. found that compared to beef steak, minced
beef was more rapidly digested and absorbed, thereby stimulating a more rapid release of AA into
circulation and thus enhancing postprandial net protein balance in older (~74 years) males, however,
no differences in MPS were observed [61]. Further, irrespective of the coagulation mode, gelation of
milk reduces AA absorption and the postprandial rise in circulating AAs [62,63]. Other considerations
to obtain optimal digestion, absorption and synthetic kinetics in the context of ageing are chewing
efficiency [64], cooking temperature [65] and cooking time [57]. As such, digestibility may modulate
the anabolic response to protein feeding but this proposition remains contentious and requires further
thorough investigation. It is, however, without doubt that the EAA profile of animal-derived proteins
(e.g., higher leucine content) largely accounts for the robust anabolic responses to these proteins.
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In more chronic experimental designs, one study assessed the effects of a 12-week diet with
or without dairy-rich protein supplements in older adults [66]. Over this period, both groups saw
negative changes in muscle strength, but a greater loss was observed in the control group, suggesting
that protein intake might offset functional decline. In addition, the dairy protein group increased
appendicular lean mass, indicating that a dairy-rich diet may be an effective strategy to counteract
muscle loss in older adults. However, in older females habitually consuming more than the protein
RDA, an additional daily protein drink containing 30 g whey protein (with reported 87% compliance)
had no effect on muscle mass or function over a 2-year period [67], suggesting that the effectiveness of
dietary protein may depend on the nutritional status and habitual protein intake of older individuals.
In regard to exercise × protein interactions, animal-derived protein sources can enhance the
magnitude and duration of the increase in MPS in both young and older adults [47,68], therein delaying
the “muscle full” set point [47]. In order to maximise the MPS response to acute resistance exercise
(RE), research has focused on optimising protein feeding strategies, albeit mostly in younger adults.
For example, Witard et al. [44] found that ingestion of 20 and 40 g whey protein isolate increased
myofibrillar MPS above 20 g at rest and after unilateral RE in young health males, with no difference in
MPS stimulation between 20 and 40 g. This data indicates that 20 g of whey protein is sufficient to
stimulate maximal MPS post-exercise in the young with doses > 20 g leading to AA oxidation and
ureagenesis, at least in the case of unilateral RE [44]. Indeed, it is not just animal-derived whey protein
that can promote exercise × protein interactions. The slowly digested protein, casein, which elicits
prolonged hyperaminoacidemia (likely due to slow gastric emptying) [69], has been shown to stimulate
myofibrillar MPS and anabolic signalling 1–6 h post-RE [70].
Although 20 g whey protein appears to saturate MPS in young individuals, older adults appear
to be responsive to greater protein doses in the context of exercise. For example, Yang et al. [71]
found that in older males performing unilateral leg RE, whole-body leucine oxidation increased in a
dose-dependent manner with increasing amounts of whey protein isolate (0, 10, 20 and 40 g), with
rates of post-RE MPS enhanced with the highest two doses. Further, increasing amounts of protein (0,
57, 113 or 170 g) derived from ground beef elevated myofibrillar MPS both at rest and after acute RE
to a greater extent in middle-aged males (~59 years) [72]. Importantly, in older adults, the source of
animal protein can influence exercise × protein anabolic responses. For example, a study in healthy
older individuals [73] demonstrated that a single bolus of high whey protein (20 g whey protein, 3 g
total leucine) consumed immediately after RE resulted in a higher rate of MPS 4 h post-exercise than
with an isocaloric milk protein control drink (6 g milk protein). Similarly, whey protein was found to
stimulate MPS to a greater extent than casein protein when combined with RE in older (~72 years)
males [58]. Thus, the amount and source of animal-derived protein should be considered when looking
to optimise age-related anabolic responses to acute exercise.
Repeated post-exercise increases in MPS culminate over time (i.e., in response to resistance
exercise training (RET)), leading to gains in muscle mass and strength, which may be potentiated with
protein-feeding across age. Indeed, a study comparing young and older males found that whey protein
(26.2 g AA per serving) ingestion during 12 weeks RET increased mechanistic target of rapamycin
(mTOR), a “master regulator” of muscle growth, both before and after RET in younger males (compared
to exercise combined with placebo) [74]. However, in older males, there was an increase in whey
protein plus exercise-induced mTOR protein phosphorylation before RET, but this was diminished
after, perhaps suggestive of an effect of ageing on exercise and animal-protein interactions [74].
When assessing muscle mass and functional outcomes in mobility-limited older adults completing
6 months of progressive high-intensity RET, consuming 40 g whey protein daily had no greater effect on
lean mass or strength than the isocaloric (but not isoproteic) control [75]. In contrast, a recent study by
Kang et al. [76] reported that following daily whey protein (32.4 g) supplementation in frail older adults
undergoing 12 weeks of RET, grip strength, chair-to-stand time and gait speed improved to a greater
extent in the whey protein supplementation group than in the RET only group. This data suggests
that animal-derived protein can positively influence muscle function. Whilst there are conflicting
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reports (as outlined above), a meta-analysis of 22 studies (6 of which included older adults) concluded
that animal protein feeding potentiates muscle mass and function gains during RET across age [5].
Collectively, these reports indicate that animal protein supplementation when combined with exercise
training may promote muscle mass and function, however, in older adults, the outcomes may depend
on the protein dose, the duration of supplementation and/or the characteristics of the volunteers.
Hospitalisation, illness and/or advancing age can lead to a reduced appetite and a subsequent
reduction in nutrient intake, leading to a hypoenergetic state and muscle loss [77]. This situation
also presents during purposeful weight loss in the form of a reduced calorie diet, hence the need
for optimal nutritional interventions that aim to preserve muscle mass and function in the face of
energy restriction. In a recent study by Hector et al. [4], males and females aged between 35 and
65 years consumed either whey protein (27 g) or soy protein (26 g) supplements during a 14-day
weight loss diet. Postprandial MPS was reduced less with whey protein than with soy protein (or
carbohydrate (CHO) supplementation) after the intervention, which was predicted to be of importance
for the preservation of muscle mass during longer-term energy restriction. Additional support for the
use of whey protein during weight loss interventions comes from a study performed in overweight
or obese older females on a reduced calorie diet (1400 kcal/d) [78]. During a 6-month intervention,
participants received twice-daily whey protein (25 g per serving) supplements or the same does of
CHO in the form of maltodextrin. Although no differences were seen in changes to lean mass or
muscle strength between the groups, greater weight loss was achieved in the protein group, possibly a
consequence of increased satiety and ensuing declines in energy intake [78,79]. In addition, relative
to thigh volume changes, the protein group gained ~6% more muscle than the CHO group [78]. In a
separate study of older obese individuals on an 8-week weight loss diet, the addition of a 7 g whey
protein supplement consumed five times daily did not enhance weight loss, nor did it significantly
preserve lean mass [80]. There was however a greater increase in acute postprandial MPS with the
protein group [80]. Thus, evidence to date suggests that animal-derived protein feeding during energy
restriction can contribute to maintaining muscle health.
To summarise, dietary animal protein does appear to offer benefits to skeletal muscle health in
terms of protein turnover, muscle mass and muscle function across the life-course and during both
exercise and energy restriction interventions (Table 1).
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Table 1. Animal-derived proteins: effects on muscle in relation to age, exercise, energy restriction and source.
Reference Study Design Protein Composition Measurements Key Outcomes
Alexandrov et al., 2018 [49]
Data analysis of the Lifelines Cohort
31,278 males (M) and 45,355 females (F)
(n = 76,633, 44.9 ± 12.8 years, 18–91 years)
(mean ± standard deviation (SD))
Protein type/intake determined through
food frequency questionnaire (mean
protein intake per day 1 ± 0.3 g/kg)
Protein intake, muscle mass (24 h
urinary creatinine excretion)
Increased intake of total and animal protein
associated with increased creatinine excretion
in M and F
Bradlee et al., 2018 [1]
Data analysis of the Framingham Offspring study
Diet, physical activity and functional performance data
collected from M (n = 1016) and F (n = 1333) to evaluate
effects on muscle mass
Protein type/intake determined through
3-day food records
Dietary analysis, physical activity,
% muscle mass,
functional performance
Higher protein intake associated with higher %
muscle mass over a 9-year period
Higher intake of animal protein had higher %
muscle mass
In those less active, only animal protein
consumption reduced risk of functional decline
Symons et al., 2009 [41]
Healthy young adults (M n = 8, F n = 9, 35 ± 3 years) and
older (M n = 10, F n = 7, 68 ± 2 years) randomly assigned
to moderate or large protein serving (mean ± SD)
Single moderate serving (113 g; 220 kcal;
30 g protein) of 90% lean beef
Large (340 g; 660 kcal; 90 g protein)
serving of 90% lean beef
Muscle protein synthesis (MPS)
Moderate serving of beef increased MPS ~50%
in young and older adults with no further
increase seen after ingestion of a large serving
Alemán-Mateo et al., 2014 [66]
Single-blind randomised controlled trial (RCT)
Older adults randomised to habitual diet (M n = 25,
F n = 25, 69.6 ± 6.4 years) or habitual diet with ricotta
cheese (M n = 25, F n = 25, 70.8 ± 7.6 years) for 12 weeks
(mean ± SD)
12 weeks of habitual diet or habitual diet
with dairy-rich protein (210 g
ricotta cheese)
Lean mass (LM), muscle strength
LM increased in supplemented group relative
to normal diet group
Both groups lost strength but greater loss of
muscle strength in controls
Zhu et al., 2015 [67]
Randomised, double-blind, placebo-controlled design
F were randomly assigned to a high protein drink
(n = 101, 74.2 ± 2.8 years) or placebo
(n = 95, 74.3 ± 2.6 years)
(mean ± SD)
Over a 2-year period, F consumed either
daily high protein drink (30 g of whey
protein) or placebo (2.1 g protein)
Appendicular lean mass (ALM),
muscle cross-sectional area (CSA),
handgrip strength, lower limb
muscle strength, dietary analysis
Both groups showed decrease in upper arm
and calf muscle area over 2 years, but no
change in ALM
No effect of protein supplementation on
muscle mass or function after 1 or 2 years
Luiking et al., 2014 [73]
RCT
Healthy older adults were randomised to consume
either high whey protein (n = 9, 66.9 ± 4.8 years) or milk
protein control (n = 10, 71.1 ± 6.3 years) after unilateral
resistance exercise (RE)
(mean ± SD)
Single bolus of high whey protein,
leucine-enriched supplement containing
20 g whey protein, 3 g total leucine
Isocaloric milk protein control containing
6 g milk protein
MPS, dietary analysis Higher MPS with whey protein supplementthan milk protein
Witard et al., 2014 [44]
Single-blind parallel design
Young, resistance-trained M (n = 48) were randomised
to consume 0 (22 ± 3 years), 10 (20 ± 1 years),
20 (22 ± 3 years) or 40 (20 ± 1 years) g protein after a
single bout of unilateral RE
(mean ± SD)




Ingestion of 20 and 40 g whey protein
increased myofibrillar MPS above 0 g
40 g whey protein increased rates of
phenylalanine oxidation
Farnfield et al., 2012 [74]
Randomised, placebo-controlled design
Healthy young and older M completed a 12-week
resistance exercise training (RET) and were randomly
assigned to consume whey protein (young n = 8,
20.5 ± 0.7 years, older n = 9, 68.1 ± 1.6 years) or placebo
(young n = 8, 20.4 ± 0.8 years, older n = 9,
67.4 ± 1.3 years) after each exercise session
(mean ± standard error of the mean (SEM))
Whey protein containing 26.6 g amino
acids (AA) per serving





Strength increased in all volunteers
Whey protein caused greater increases in
mechanistic target of rapamycin
phosphorylation than placebo in both
age groups
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Table 1. Cont.
Reference Study Design Protein Composition Measurements Key Outcomes
Robinson et al., 2013 [72]
RCT
35 M (59 ± 2 years) were randomly assigned to 1 of 4
protein groups with and without RE (n = 7 per group)
(mean ± SEM)
Consumed 0, 57 g (12 g protein), 113 g
(24 g protein) or 170 g (36 g protein) of
ground beef
MPS, leucine oxidation
Ingestion of 170 g beef increased myofibrillar
MPS at rest and after RE more than
other amounts
Higher leucine oxidation with increasing
amounts of beef
Yang et al., 2012 [71]
RCT
Older M (n = 37, 71 ± 4 years) completed a bout of
unilateral leg RE prior to ingesting 1 of 4 protein doses
(mean ± SD)
0, 10, 20 or 40 g whey protein isolate MPS, leucine oxidation
Whole-body leucine oxidation increased in a
dose-dependent manner
MPS increased with 20 and 40 g whey protein
but not lower doses
20 and 40 g whey protein ingestion
post-exercise increased MPS above 0 and 10 g
exercise rates
Haub et al., 2002 [81]
RCT
M randomly assigned to beef-containing
(n = 10, 63 ± 3 years) or lacto-ovo-vegetarian (n = 11,
67 ± 6 years) diet throughout 12-week RET
(mean ± SD)
Beef-containing diet: 0.6 g protein/kg/d
from beef
Lacto-ovo-vegetarian diet:
0.6 g protein/kg/d from soy
Strength, muscle CSA,
dietary analysis
No difference between dietary groups in terms
of strength improvements
CSA of m. vastus lateralis increased with
training similarly in both groups
Chalé et al., 2013 [75]
Randomised, double-blind controlled design
Older mobility-limited adults were randomised to
protein (n = 42, 78 ± 4 years) or isocaloric control (n = 38,
77.3 ± 3.9 years) and high intensity RET for 6 months
(mean ± SD)
Whey protein: 40 g/d
Isocaloric control
Strength, muscle CSA, LM,
dietary analysis
LM, muscle CSA and muscle strength
increased in both groups but there was no
difference between groups
Kang et al., 2019 [76]
Multicentre, interventional, two parallel-group
case-control design
Frail older adults received daily protein
supplementation (n = 49, 78 ± 7 years) or no
supplementation (n = 66, 76.8 ± 7 years) combined with
RET for 12 weeks
(mean ± SD)
Protein containing 32.4 g of whey protein Handgrip strength, gait speed, chairrise test
Handgrip strength, chair-stand time and gait
speed improved to a greater extent in the
group that received whey protein
Hector et al., 2015 [4]
Randomised, double-blind design
Adults were randomised to receive whey protein (n = 14,
52 ± 2 years), soy protein (n = 14, 52 ± 2 years) or
carbohydrate (CHO) (n = 12, 48 ± 3 years) during a
14-day hypoenergetic diet (mean ± SEM)
Twice daily supplements of:
Whey protein: 27 g/supplement
or Soy protein: 26 g/supplement
or Isoenergetic CHO
Hypoenergetic diet: −750 kcal/d
MPS, dietary analysis
Whey protein stimulated MPS to greater extent
than soy protein or CHO pre-intervention
Postprandial MPS was reduced by whey
protein less than soy protein and CHO
post-intervention
Mojtahedi et al., 2011 [78]
Randomised, double-blind parallel design
Overweight/obese, postmenopausal F prescribed
reduced calorie diet and randomised to protein (n = 13,
64.7 ± 4.4 years) or CHO (n = 13, 64.6 ± 5.2 years) for
6 months
(mean ± SD)
Reduced calorie diet: 1400 kcal/d, 15%,
65% and 30% energy from protein, CHO
and fat, respectively.
Protein: 2 × 25 g/d whey protein
CHO: 2 × 25 g/d maltodextrin
LM, strength
More weight lost in protein group
No differences changes to LM or strength
Relative to thigh volume changes, protein
group gained more muscle than CHO group
Coker et al., 2012 [80]
Older adults (n = 12) randomised to 8-week calorie
restriction diet using (i) 7% weight loss with meal
replacement (70 ± 2 years) or (ii) competitive meal
replacement (68 ± 2 years)
(mean ± SEM)
Whey protein (7 g) plus essential amino
acids (EAA) formulation (6 g) in form of
meal replacement (5 ×/d) or competitive
meal replacement
LM, MPS, dietary analysis Whey protein/EAA did not preserve LM butthere was an increase in acute FSR
Abbreviations: AA, amino acids; ALM, appendicular lean mass; CHO, carbohydrate; CSA, cross-sectional area; EAA, essential amino acids; F, females; LM, lean mass; M, males; MPS,
muscle protein synthesis; RCT, randomised controlled trial; RE, resistance exercise; RET, resistance exercise training; SD, standard deviation; SEM, standard error of the mean; d, day.
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2.2. Bone
Given the importance of protein for bone turnover and matrix remodelling, particularly during
growth and ageing [12,13], it is unsurprising that dietary protein has a critical role in modulating bone
health. When assessing the effects of animal protein sources on phenotypic (e.g., mass) and functional
(e.g., strength) outcomes related to bone health, two recent studies have both reported positive findings.
In a cross-sectional study by Durosier et al. [82], bone mineral density (BMD), bone strength and
distal radius and tibia bone microstructures were assessed in 746 older females (~65 years). There
was a positive association between animal and dairy protein intake with predicted bone failure load
(calculated as: force for which 2% of the bone would be loaded beyond 0.7% strain [83]) and stiffness
of the distal radius and tibia, which was largely attributed to observed changes in the trabecular bone
microstructures. A separate cross-sectional study using dietary intake questionnaire data from >1000
older males from the Osteoporotic Fractures in Men Study, showed positive associations between
animal protein intake and bone strength [25]. The findings of each of these studies indicate beneficial
effects of animal protein sources on bone strength in older adults.
As previously mentioned, it has also been suggested that diets rich in animal proteins could
have negative impacts on bone health [15]. One hypothesis surrounding this relates to the greater
acid-forming properties of meat and dairy foods, where it is thought that bone loss could occur through
release of salts from the bone to balance the generation of acid [84,85]. Despite this, many studies have
found no adverse effects of meat-based protein sources on urinary calcium excretion or other markers
of bone health. For example, data from the Framingham Offspring Study found that in 615 older adults,
lower protein intake overall was associated with increased bone loss over a 4-year period, while higher
intake of animal protein was not associated with decreased BMD [86]. Similarly, in a randomised
crossover study of healthy postmenopausal females that directly compared the effects of a high (20%
of energy as protein) versus low (12% of energy as protein) meat diet on calcium homeostasis and bone
turnover, it was reported that eating a high-meat diet for 16 weeks had no effect on urinary calcium
excretion, retention or on circulating markers of bone turnover [87]. A further randomised crossover
study also in post-menopausal females studied the effects of a low (10% of energy from protein) versus
high (20% of energy from protein) protein and potential renal acid load (PRAL) diet for 7 weeks [88].
The high meat/high PRAL diet led to an increase in both the fractional rate of calcium absorption and
urinary calcium excretion, while there was no change in markers of bone resorption or formation.
While more evidence is required, these findings indicate that a diet high in animal protein does not
adversely affect bone health.
The role of animal-derived protein intake and exercise-induced adaptations on bone health
is less studied than protein intake alone. One study by Ballard et al. [89] included young males
and females undergoing 6 months of RET and aerobic exercise training, who received a twice daily
protein-containing supplementation (84 g/d total protein) or CHO. The protein group had higher
plasma insulin-like growth factor-1 levels at the end of exercise training, while serum bone alkaline
phosphatase (ALP) also increased with training and tended to be higher in those who received protein.
The protein group also had higher concentrations of the bone turnover marker N-terminal telopeptide
(NTx). Conversely, during RET in healthy young females, 10 days of high protein (in the form of
2.4 g/kg/d purified whey protein) supplementation during the end of 12 weeks of RET had no effects on
bone metabolism, possibly a reflection of the short exercise and supplement period [90]. In relation to
advancing age, a study by Holm et al. [91] saw postmenopausal females complete 24 weeks of RET with
or without a 10 g whey protein-containing supplement (albeit with calcium and vitamin D) after each
training session. The nutrient group had greater increases in BMD as well as increased bone formation
(with increased osteocalcin) [91]. Although these effects cannot necessarily be attributed to higher
animal protein per se (due to the multi-nutrient supplement), these findings suggest that beneficial
effects on bone metabolism can be gained in older adults with long-term training and animal-derived
protein provision.
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It is generally understood that diet-induced weight loss can have adverse effects on bone health
through increased bone resorption [12]. However, the effects of animal protein during weight loss on
(markers of) bone health remains poorly studied. One double-blind, randomised, placebo-controlled
trial addressed this via whey protein supplementation (20 and ≥40 g) during a combined resistance
and aerobic exercise training program in obese/overweight adults [92]. In this study, whey protein,
regardless of dose, had no effect on BMD or bone mineral content (BMC) during the intervention.
A further trial studied overweight males and females undergoing 12 weeks of energy restriction
(6–6.3 MJ/d) with a high-protein (27% of energy from meat, poultry and dairy protein) or standard weight
loss diet (16% protein energy) [93]. In this trial, there were no differences in markers of bone turnover
or calcium excretion between the groups. A separate study addressed whether a high dairy protein
diet containing high calcium (~2400 mg/d) would influence bone turnover during energy restriction in
overweight adults [3]. In this study, energy restriction decreased urinary calcium excretion regardless
of the calcium content. Following the weight loss intervention, there was an observed increase in
bone resorption (determined as an increase in the bone resorption marker deoxypyridinoline), in both
groups; however, the diet high in calcium minimised overall bone turnover. Bone health biomarkers
were also assessed in a study of pre-menopausal overweight/obese females given differing amounts
of dairy protein (dietary protein 30% or 15% of energy) during diet- and exercise-induced weight
loss [94]. There was an increase in C-terminal telopeptide of collagen type-I (CTX; a marker for bone
turnover), osteocalcin (a marker for bone formation) and urinary deoxypyridinoline in the low (<2%
energy from protein) and adequate (dietary protein 15% of energy) protein groups, while no changes
in resorption markers but an increase in the bone formation marker amino-terminal pro-peptide of
collagen I (P1NP) were seen in the high (30% energy from protein) protein group [94]. These studies
indicate that high-protein diets, particularly when higher in calcium, may protect against bone loss
during periods of energy restriction and weight loss. Further research is required to directly study the
individual effects of protein and calcium on bone health.
In summary, diets high in animal protein appear to be beneficial for bone throughout the lifespan
and may offer benefits to bone metabolism in older adults with exercise training. There is also evidence
to suggest that animal protein, especially with calcium sufficiency, may counteract some negative
effects that weight loss has on bone mass (Table 2).
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Table 2. Animal-derived proteins: effects on bone in relation to age, exercise, energy restriction and source.
Reference Study Design Protein Composition Measurements Key Outcomes
Hannan et al., 2000 [86]
615 older adults (75 ± 4.4 years, 391 females (F),
224 males (M)
(mean ± standard deviation (SD))
Relationship between dietary protein and subsequent
4-year change in bone health
Protein type/intake determined through
food frequency questionnaire
Protein intake, bone mineral
density (BMD)
Lower protein intake associated with increased
bone loss
Higher intake of animal protein not associated
with decrease in BMD
Roughead et al., 2003 [87]
Randomised crossover design
Healthy postmenopausal F (n = 15, 60.5 ± 7.8 years)
randomised to 8-week high-meat
and 8-week low-meat diet
(mean ± SD)
High-meat diet: 20% of energy as protein
Low-meat diet: 12% of energy as protein




High-meat diet did not adversely affect urinary
calcium excretion, calcium retention or
markers of bone metabolism
Cao et al., 2011 [88]
Randomised crossover design
Postmenopausal F (n = 16, 56.9 ± 3.2 years, mean ± SD)
randomised to two diets: low protein, low potential renal
acid load (PRAL) and high protein, high PRAL diet.
Low protein, low PRAL diet: 10% of energy
as protein
High protein, high PRAL diet: 20% of
energy as protein
Each diet was 7 weeks separated by 1 week
Calcium absorption, bone
markers, dietary analysis
No effect of high meat/PRAL diet on markers
of bone metabolism
Increased fractional rate of calcium absorption
and urinary calcium excretion
Durosier-Izart et al., 2017 [82]
Cross-sectional study design
746 F (65 ± 1.4 years, mean ± SD)
Associations between animal (separated into non-dairy
and dairy) and vegetable protein sources and bone health
Protein type/intake determined through
food frequency questionnaire
Areal BMD, distal radius and
tibia bone microstructures, bone
strength, protein intake
Predicted failure load and stiffness at distal
radius and tibia positively associated with
total, animal and dairy protein intake
Langsetmo et al., 2018 [25]
Cross-sectional study design
Questionnaire data from 1016 M
(84.3 ± 4 years, mean ± SD)
Association of dairy, non-dairy and plant-derived protein
intake on bone health




Higher dairy protein associated with higher
estimated failure load at the distal radius and
distal tibia
Higher non-dairy animal protein associated
with higher total BMD
Ballard et al., 2006 [89]
Randomised controlled trial
51 younger adults (18–25 years, 28 M, 23 F) were
randomised to either protein (20.9 ± 2.4 years) or placebo
(21.1 ± 2.2 years) supplementation during a 6-month
training intervention of alternating resistance exercise
training (RET) and aerobic exercise 5 ×/week
(mean ± standard error of the mean (SEM))
Twice daily protein (42 g protein, 24 g
carbohydrate (CHO), 2 g fat)
Isocaloric CHO supplement (70 g CHO)
Bone markers, protein intake
Increases in plasma insulin-like growth factor-I
greater in protein group
Serum bone alkaline phosphatase increased
over time and tended to be higher in
protein group
N-terminal telopeptide concentrations greater
in protein group
Mullins & Sinning, 2005 [90]
Randomised, double-blind, placebo-controlled design
24 healthy, untrained, young adult F (18–29 years)
engaged in 12-week RET 3 d/week and were randomised
to protein (22.8 ± 0.9 years) or placebo (22.7 ± 1.1 years)
during the final 10 days
(mean ± SEM)
High-protein diet (during final 10 days):
purified whey protein for daily protein
intake of 2.4 g/kg/d
Control: equivalent dose of
isoenergetic CHO
Bone markers, dietary analysis High protein intake for final 10 days of REThad no effects on bone metabolism
Holm et al., 2008 [91]
Randomised, double-blind, placebo-controlled design
Postmenopausal F were randomised to a
protein-containing nutrient supplement (n = 13,
55 ± 1 years) or placebo (n = 16, 55 ± 1 years) in
conjunction with 24-week RET (mean ± SEM)
Nutrient supplement containing: 10 g
whey protein, 31 g CHO, 1 g fat, 250 mg
calcium and 5 µg vitamin D. 730 kJ in total.
Placebo supplement containing: 6 g CHO
and 12 mg calcium. 102 kJ in total.




Nutrient group had greater increase in BMD at
the femoral neck than controls
Increased bone formation and osteocalcin
following training in nutrient group
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Table 2. Cont.
Reference Study Design Protein Composition Measurements Key Outcomes
Wright et al., 2017 [92]
Randomised, double-blind, placebo-controlled design
Obese/overweight adults were randomised to 0 g protein
(n = 68, 50 ± 7 years) 20 g protein (n = 72, 48 ± 8 years) or
≥40 g protein (n = 46, 49 ± 8 years) combined with
36-week RET and aerobic exercise training 3 d/week for
36 weeks
(mean ± SD)
Unrestricted diet in combination with whey
protein supplementation (0, 20, 40 or 60 g/d)
(40 and 60 g group combined to form a
≥40 g group for analysis)
BMD, bone mineral content
(BMC), protein intake
Whey protein, regardless of dose, had no effect
on BMD or BMC during training
Farnsworth et al., 2003 [93]
Parallel design
57 overweight adults randomised to either high protein
(M n = 7 51.9 ± 3.3 years, F n = 21, 50.6 ± 2.7 years) or
standard protein (M n = 7 48.6 ± 3.2 years, F n = 22,
50.6 ± 2.1 years) diet during 12 weeks of energy
restriction and 4 weeks of energy balance
(mean ± SEM)
High-protein diet of meat, poultry and
dairy foods (27% of energy as protein, 44%
as CHO, and 29% as fat)
Standard protein diet low in those foods
(16% of energy as protein, 57% as CHO,
and 27% as fat)
Diets during 12 weeks of energy restriction




Markers of bone turnover and calcium
excretion unchanged between diet groups
Bowen et al., 2004 [3]
Randomised study design
Overweight adults were randomly assigned to
isoenergetic diets high in dairy protein (M 49.4 ± 3.2 years,
F 46.5 ± 2.4 years) or mixed source protein
(M 48.7 ± 4.2 years, F 46.1 ± 2.7 years) during 12 weeks of
energy restriction and 4 weeks of energy balance
(mean ± SEM)
Isoenergetic diets (34% of energy as
protein) high in either dairy protein
(~2400 mg calcium/d) or mixed protein
sources (~500 mg calcium/d)
Calcium excretion, bone
markers, dietary analysis
Urinary calcium excretion decreased
independently of diet
Greater increase in bone resorption marker
deoxypyridinoline with mixed protein
Increased osteocalcin in mixed protein group
Josse et al., 2012 [94]
Randomised, controlled, parallel intervention design
Premenopausal overweight and obese F were randomised
into high protein/high dairy (30 ± 1 years), adequate
protein/medium dairy (26 ± 1 years) or adequate
protein/low dairy protein (28 ± 1 years)
(mean ± SEM)
High protein/high dairy: dietary protein
(30% of energy), dairy foods (15% energy
from protein) and dietary calcium
(~1600 mg/d)
Adequate protein/medium dairy: dietary
protein (15% of energy), dairy foods (7.5%
energy from protein) and dietary calcium
(~1000 mg/d)
Adequate protein/low dairy: dietary
protein (15% of energy), dairy foods (<2%
energy from protein) and dietary calcium
(<500 mg/d)
Bone markers
With low dairy, C-terminal telopeptide of
collagen type-I, urinary deoxypyridinoline and
osteocalcin increased
With high dairy, osteocalcin, amino-terminal
propeptide of collagen I increased with
resorption markers unchanged
Abbreviations: BMC, bone mineral content; BMD, bone mineral density; CHO, carbohydrate; F, females; M, males; PRAL, potential renal acid load; RET, resistance exercise training; SD,
standard deviation; SEM, standard error of the mean.
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3. Plant-Derived Proteins: Effects in Relation to Age, Exercise, Energy Restriction and Source
3.1. Skeletal Muscle
Given the widely reported benefits of animal-derived protein sources on muscle health across the
life course, as outlined in Section 2.1 (e.g., References [41,49–51]), yet also considering the sustainability
of animal- versus plant-derived protein [6], observational studies have assessed the relationship
between plant protein consumption and the preservation of muscle health across age. One cohort
observational study found that plant-derived protein intake was not positively associated with leg
lean mass in older adults, but animal-derived protein was [49]. Additionally, a large (n = 2066)
longitudinal cohort study of older adults (70–79 years) also showed the importance of protein quality
and composition for maintaining muscle mass. In this study, plant protein was not related to a reduced
loss of lean mass and appendicular lean mass, however, animal protein was [95]. Similar observations
were also seen in a cross-sectional study by Sahni et al. [96] in a wide-ranging age-group (29–86 years),
where plant protein intake did not positively associate with leg lean mass, but high total and animal
protein intake did. In this study, quadricep strength was greater in the highest plant protein intake
quartile comparatively to the lowest quartile, suggesting that sufficient plant protein intake may help
to reduce age-related loss of strength.
Despite a lack of convincing evidence from observational cohorts in regard to plant-derived
protein (versus animal) and muscle health, a number of studies have gone on to directly
compare musculoskeletal-related physiological responses between plant- and animal-derived protein.
For example, in healthy young males, ingestion of whey protein stimulated MPS to a greater extent than
soy protein, despite matched EAA content [97]. This phenomenon of a diminished MPS response also
translates into ageing as Yang et al. [71] demonstrated that, in rested older males, ingestion of either
20 or 40 g whey protein increased MPS, while ingestion of either dose of isolated soy protein elicited
no such increases. Furthermore, heightened rates of leucine oxidation were observed in response to
ingestion of both 20 and 40 g of isolated soy protein, which may indicate AA oxidation [98]. Similar
observations were shown in middle-aged males, whereby postprandial rates of MPS were lower after
soy protein ingestion compared to beef [35]. Considering these findings, it may be that consumption of
a greater quantity of plant-derived protein may be required to overcome the reduced anabolic response
of this protein source. Indeed, a recent investigation by Gorissen et al. [99] in older males demonstrated
that although 35 g wheat protein did not stimulate MPS to the same degree as equal amounts of
whey or casein protein, when the sources were matched for leucine content (4.4 g), consumption of
60 g wheat protein resulted in a greater MPS response than 35 g whey protein. Interestingly, plasma
leucine concentrations increased to a greater extent following whey protein ingestion, with a more
gradual appearance of plasma AA after wheat consumption. Sustaining postprandial AA increases
may be beneficial in older populations through continued increases in MPS [60], however the practical
challenge of getting older adults to consume greater amounts of plant-derived protein to achieve this
must be considered given the reported lack of appetite [100] and rapid satiety [101] in older age.
Interestingly, some types of plant-derived proteins (e.g., potato and quinoa) contain adequate
amounts of all EAA [9] and thus may offer sufficient anabolic alternatives to animal-derived proteins.
Indeed, a recent study in young women found that 25 g of potato protein twice daily for 2 weeks
(1.6 g/kg/d total protein) increased integrated MPS above baseline at rest, with no increase observed in
those consuming a control diet (0.8 g/kg/d total protein) [102]. Whilst this greater anabolic response
could be attributed simply to the greater amount of protein, it still demonstrates the ability of potato
protein to stimulate MPS above a baseline diet already containing the RDA of protein, at least in
younger individuals. Further, since it is well recognised that plant-derived protein sources can have
inferior anabolic properties compared to animal-derived protein sources, the notion of blending
different plant-derived sources together (in order to exploit the favourable AA profile of each) has been
suggested in order to improve the anabolic quality of plant-derived protein sources. Protein blends,
including plant–plant protein blends, are discussed in more depth in Section 5.
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Considering protein × exercise interactions, it has been shown that combining whey protein
ingestion with RE/T capitalises upon postprandial stimulation of MPS responses, therein promoting
gains in muscle mass and strength [71,97]. However, the efficacy of plant-derived (as opposed to
animal-derived) protein to potentiate exercise-induced anabolism is less well studied. In the context
of acute exercise, whey protein ingestion in conjunction with unilateral RE elicited a greater MPS
response than that of an EAA-matched (10 g) soy protein in young males [97]. However, both whey
and soy protein increased MPS rates to a greater extent than casein protein in both rest and exercise
conditions. This may be due to the slower nature of casein digestion and subsequent aminoacidemia,
with whey protein increasing aminoacidemia to a more rapid and greater degree than intermediary soy
protein [97]. Conversely, comparable MPS stimulation was observed post-exercise in those consuming
potato protein (25 g twice daily) and control diet groups over a 2-week period, highlighting the potency
of RE as an anabolic stimulus [102]. In the context of ageing, a randomised cross-over study by
Wilkinson et al. [103] found that the ingestion of soy protein (18.2 g) with acute RE increased MPS
responses to a lesser degree than that of isonitrogenous whey protein in young males. This was despite
greater total plasma AA and similar leucine concentrations following consumption of soy protein.
In regard to chronic exercise × plant-protein interactions, a 6-week whole-body RET (3 d/week)
intervention involving supplementation of whey or soy protein (1.2 g/kg, consumed as three equal
doses per day) increased lean mass and strength in young adults to a greater degree than an isocaloric
maltodextrin placebo [104]. Furthermore, no differences between the protein groups were observed,
and fractional breakdown rate remained constant throughout, suggesting greater MPS, independent
of protein source. Conversely, some have reported no effects of whey or soy protein on muscular
adaptations to RET [105] and others have shown that compared to milk, soy protein induced inferior
gains in muscle hypertrophy in young males [106]. Interestingly, other plant-derived protein sources
have demonstrated similar benefits when combined with RET. For example, twice daily ingestion
of pea or whey protein (26.6 g protein, 2.9 g leucine and 23.9 g protein, 3.9 g leucine, respectively)
combined with progressive upper-body RET each improved bicep thickness after 42 and 84 days in
young males [107]. Furthermore, sub-analysis of weaker (at study start) adults showed that consuming
pea protein increased muscle thickness to a greater degree than whey protein or placebo. Similarly,
consumption of rice protein isolate (48 g protein, 3.84 g leucine, 3×/week) during 8 weeks of whole-body
RET improved lean mass gains and body composition to a comparable extent as isonitrogenous whey
protein (48 g protein, 5.5 g leucine) in young males [23]. In a study of older males, the addition of
a diet high in beef or soy protein (0.6 g protein/kg/d from beef or soy, respectively) to whole-body
RET for 12 weeks, each increased strength and m. vastus lateralis cross-sectional area to a similar
extent [81]. Interestingly, the comparable increases in skeletal muscle mass independent of protein
source in a number of these studies [23,81] may be a result of consuming greater protein amounts (and
subsequently leucine), thereby offsetting the often reduced EAA content with plant-derived proteins
and supporting augmentation of RET-induced gains in lean mass. Thus, sustained consumption of
greater quantities of plant-derived proteins in conjunction with RET may be sufficient to support
increases in muscle mass (Table 3).
Nutrients 2020, 12, 2670 15 of 35
Table 3. Plant-derived proteins: effects on muscle in relation to age, exercise, energy restriction and source.
Reference Study Design Protein Composition Measurements Key Outcomes
Hartman et al., 2007 [106]
Randomised, controlled, parallel intervention design
Soy protein (n = 19) vs. milk (n = 18) vs. carbohydrate
(CHO) control (n = 19)
Healthy young males (M) (18–30 years). 12 weeks






2 × supplement, post exercise + 1 h
Fat- and bone-free mass (FBFM),
fibre cross (CSA), plasma amino
acid (AA) profile
No increased FBFM in soy group
Soy protein increased type I fibre CSA after 12 weeks, however milk
greatly increase type I + II CSA
Soy protein increased post-ingestion plasma leucine and EAA
profiles similar to milk
Increased plasma insulin immediately after ingestion
similar to milk
Tang et al., 2009 [97]
Randomised, controlled, parallel intervention design
Soy vs. whey vs. casein protein
All groups n = 6
Healthy young M (22.8 ± 3.9 years, mean ± standard
error of the mean (SEM))
Unilateral leg press and knee extension (4 sets, 10–12
repetition maximum (RM))
Soy protein—22.2 g protein, 1.8 g leucine
Whey protein—21.4 g protein, 2.3 g leucine
Casein protein—21.9 protein, 1.8 g leucine
All provided ~10 g EAA
Protein drink post exercise.
Rest and exercise muscle
fractional synthesis rates (FSR),
plasma AA profile
Soy and whey protein increased rest muscle FSR above casein
Soy protein + exercise muscle FSR increased above casein protein,
however a greater increase was seen in whey protein + exercise
Soy protein ingestion increase EAA + leucine profiles above casein
protein, with whey protein ingestion
increasing both to a greaterdegree
DeNysschen et al., 2009 [105]
Randomised, double-blind, controlled parallel
intervention design
Soy protein (n = 10) vs. whey protein (n = 9) vs. CHO
placebo (n = 9)
Overweight males (21–50 years, mean 38 years, body
mass index (BMI) 25–30)
12 weeks 3 d/week whole-body RET
Soy protein—25.8 g
Whey protein—26.6 g





All groups increased strength pre to post
Total cholesterol decreased in all groups
No differences between groups for any measures
Wilkinson et al., 2007 [103]
Randomised cross-over intervention design
Soy protein vs. milk
n = 8
Healthy young M (21.6 ± 0.3 years, mean ± SEM)




Protein drink post RE
AV balance-based FSR and
fractional breakdown rate (FBR),
net balance, plasma AA profile
A significant, but lower increase in total AA and muscle FSR after
consumption of soy protein vs. milk
Soy protein ingestion resulted in a shorter period of positive net
protein balance and area under the curve compared to milk
Total AA net balance remained elevated after milk consumption vs.
soy protein
Luiking et al., 2011 [108]
Randomised, single-blind parallel intervention design
Soy protein (n = 10) vs. casein protein (n = 12)
Healthy young adults (M/females (F) 50:50,
22 ± 1 years, mean ± SEM)
Soy protein—3.4 g protein/100 mL
Isonitrogenous casein
protein—2.95 g/100 mL
Enteral ingestion (2 mL/kg/bw/h)
AV balance based FSR & FBR,
net balance, plasma AA profile
Greater net uptake of glutamate, serine, histidine and lysine from
casein vs. soy protein
Reduced intramuscular branch AA concentrations from soy
ingestion compared to casein
No differences in muscle protein synthesis (MPS) or muscle protein
breakdown between protein sources
Joy et al., 2013 [23]
Randomised, double-blind, parallel
intervention design
Rice protein vs. whey protein isolate
All groups n = 12
Healthy young males (21.3 ± 1.9 years,
mean ± standard deviation (SD))
Periodic whole-body RET
Rice protein—48 g protein, 80 mg/g leucine
Isonitrogenous
whey protein isolate—48 g protein,
115 mg/g leucine




Both groups increased lean mass (LM), bicep/quadricep thickness,
with no differences between groups
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Table 3. Cont.
Reference Study Design Protein Composition Measurements Key Outcomes
Babault et al., 2015 [107]
Randomised, double-blind, controlled parallel
intervention design
Pea protein (n = 53) vs. whey protein (n = 54) vs.
placebo (n = 54)
Healthy young M
(21.9 ± 3.7 years, mean ± SD)
6 weeks 3 d/week progressive strength training, elbow
flexor/extensor
Pea protein—26.6 g protein, 2.9 g leucine
Whey protein—23.9 g protein
Placebo—3.9 g
maltodextrin
Ingested twice daily morning/afternoon
(post exercise) for 6 weeks
Bicep thickness, maximal
voluntary torque, 1-RM
All groups increased bicep thickness compared to baseline after 42
and 82 days, no difference between groups
Baseline weakest volunteers supplemented with pea protein
demonstrated increased bicep thickness between 42 and 84 days
Candow et al., 2006 [104]
Randomised, double-blind, controlled parallel
intervention design
Soy protein vs. whey protein vs. placebo
All groups n = 9
Healthy young adults
(M/F 1:2, 23 ± 6 years, mean ± SD)
6 weeks 3 d/week whole-body RET
Soy and whey protein—1.2 g/kg
Placebo—1.2 g/kg maltodextrin, isocaloric




Both soy and whey protein groups increased LM and strength
greater than the placebo group
All groups increased muscle FBR similarly
Yang et al., 2012 [71]
Parallel intervention, controlled design
Soy protein 20 g or 40 g vs. whey protein 20 g or 40 g
vs. water
All groups n = 10
Healthy older M (71 ± Unilateral knee extension
(3 sets, 10-RM).
Soy protein—20 g protein, 1.6 g leucine
Soy protein—40 g protein, 3.2 g leucine
Whey protein—20 g protein, 2 g leucine
Whey protein—40 g, 4 g leucine
Water control
Protein drink post exercise
Myofibrillar FSR (rest and RE)
plasma AA profile,
leucine oxidation
No increase in rest myofibrillar FSR in either 20 or 40 g soy
protein groups
Increased RE myofibrillar FSR in 40 g soy protein group
Significant increases in myofibrillar FSR for all whey protein
groups, rest + RE
20 and 40 g soy protein increased leucine oxidation to
similar degrees
Deibert et al., 2011 [109]
Randomised controlled intervention design
Whole-body RET with/without soy protein
Healthy moderately overweight older M
(55.7 ± 4.6 years, BMI 27.7 ± 2.1, mean ± SD)
12 weeks 2 d/week progressive whole-body RET
50 g soy protein yoghurt—26.7 g protein
Control—RET only




Decreased waist circumference and fat mass and increased fat free
mass in soy protein supplemented group
Improved glycaemic control and metabolic markers in soy
protein-supplemented group
Both groups increased in strength and coordination
Gorissen et al., 2016 [99]
Randomised, double-blind, controlled parallel
intervention design
35 g wheat protein vs. 35 g or 60 g wheat protein
hydrolysate vs. 35 g micellar casein protein, 35 g
whey protein
All groups n = 12
Healthy older M (71 ± 1 years, mean ± SEM)
Single protein drink ingestion
Wheat protein—35 g
Wheat hydrolysate protein—35 g
Wheat hydrolysate protein—60 g





Ingestion of 35 g wheat protein did not increase myofibrillar FSR as
much as 35 g whey or 35 g casein protein
60 g wheat hydrolysate stimulated myofibrillar FSR to a greater
degree than 35 g whey protein 2–4 h post-ingestion
Whey protein ingestion had a greater plasma leucine increase
compared to 60 g wheat hydrolysate protein
Plasma AA content was more persistent following 60 g wheat
hydrolysate ingestion
Oikawa et al., 2020 [102]
Single blind, parallel group design
24 F randomised to potato protein (n = 12, 20 ± 3) or
control (n = 12, 21 ± 3) diet for 2 weeks plus unilateral
RET (3 ×/weeks) (mean ± SD)
Potato protein—25 g 2 ×/d (1.6 g/kg/d
total protein)
Control—0.8 g/kg/d total protein
(breakdown of AA composition within
each supplement can be found in
original article)
Myofibrillar protein synthesis,
cell signalling, baseline body
composition and strength,
dietary analysis
No difference in total kcals or percentage fat intake between groups
Protein intake was significantly greater in the potato protein group
compared to control
MPS increased above baseline at rest in the potato protein, but not
control, group
MPS increased similarly above baseline with exercise in
both groups
In response to exercise, total protein kinase B (PKB/Akt) increased
compared to baseline
Main effect of time for total mechanistic target of rapamycin and
ribosomal protein s6
Abbreviations: AA, amino acids; BMI, body mass index; CHO, carbohydrate; CSA, cross-sectional area; EAA, essential amino acid, FBFM, fat- and bone-free mass; F, females; FBR;
fractional breakdown rate; FSR, fractional synthesis rate; LM, lean mass; M, males; MPS, muscle protein synthesis; RE, resistance exercise; RET, resistance exercise training; RM, repetition
maximum; SD, standard deviation; SEM, standard error of the mean.
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3.2. Bone
Despite plant-derived proteins varying in AA composition depending on the plant protein source
(i.e., corn and wheat), similar sulphur content has been reported across these sources [110] suggesting
possibly ubiquitous effects on bone health. Although limited studies directly comparing the effects
of protein sources on bone health are available, a recent meta-analysis by the National Osteoporosis
Foundation was undertaken evaluating the influence of differing protein source supplementation on
the bone health of healthy adults [111]. This analysis of randomised controlled trials concluded that
supplementation of either soy or animal protein for >1 year was beneficial on multiple outcomes of bone
health (BMD in lumbar spine, total hip, femoral neck and total body), with neither more advantageous
than the other. Moreover, a separate randomised controlled trial by Dawson-Hughes et al. [2] showed
that during a 3-year supplementation period of calcium and vitamin D in older males and females,
greater protein intake (irrespective of the source) was associated with increased BMD. It is important
to note that such improved bone-related outcomes resulting from increased protein intake require
sufficient dietary calcium intake, and the relationship between protein intake and BMD was not
observed in the control group for this study [2]. Despite these findings, translation of the results
from these supplementation studies into additional clinically relevant outcomes remains unclear. For
instance, one recent cohort study showed that greater protein intake of animal protein was associated
with reduced risk of hip fracture in older males, whereas plant-derived protein was not [24], which
could be related to the higher calcium content in animal-derived versus plant-derived protein sources.
Comparatively, in a separate 5-year cohort study of older males and females, greater protein intake
was associated with reduced fracture risk, but this was not related to protein source [112].
Variable findings on the effect of protein sources on bone health may result from additional
constitutive elements present, such as isoflavones, which are predominantly present in soy protein
products. In support of this, epidemiological studies have associated a decreased risk of bone loss and
hip fracture risk in older Asian populations with consuming proportionally more soy protein [113].
Structurally similar to oestrogens, isoflavones have been demonstrated to reduce bone turnover
through a combination of stimulating bone formation and inhibiting bone reabsorption [114,115].
Furthermore, isoflavone inclusion rather than protein alone may be an important aspect for bone
health, as in a 24-week supplementation period in perimenopausal women, only supplementation with
isoflavone-rich soy was able to attenuate losses in BMD and BMC when compared to isoflavone-poor soy
protein or whey protein control [116]. However, results from isoflavone supplementation studies have
been inconsistent, with supplementation of isoflavone-enriched products (110 ng/d) alongside habitual
diets for 1 year not shown to prevent postmenopausal bone loss [117], suggesting that increased protein
consumption may also be needed. That said, soy isoflavanols’ (70 mg/d) supplementation increased
bone formation markers (i.e., bone-specific ALP and osteocalcin), whilst reabsorption markers remain
unchanged (i.e., CTX and NTx) [118]. Although further investigation is required to elucidate potential
benefits of isoflavones and corresponding protein supplementation, high habitual soy protein intake
(containing isoflavones) may be beneficial for the maintenance of bone health and/or the attenuation of
bone loss.
To summarise, plant-derived dietary protein has the potential to induce similar anabolic responses
to animal-derived protein, particularly when matched for leucine, in the context of acute and chronic
exercise. Additionally, plant protein alone (i.e., not in the context of exercise/energy restriction)
demonstrates beneficial effects on certain aspects of bone health (e.g., BMD), although this may be in
part due to the effects of plant protein containing isoflavanols (Table 4).
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Table 4. Plant-derived proteins: effects on bone in relation to age, exercise, energy restriction and source.
Reference Study Design Protein Composition Measurements Key Outcomes
Roughead et al., 2005 [87]
Randomised cross-over intervention study design
Low meat soy supplemented vs. high meat
n = 13
7 weeks, healthy postmenopausal females (F)
(59.9 ± 5 years, mean ± standard deviation (SD))
Low meat soy supplemented—55 g/d
meat, 25 g soy protein




of bone mineral status
No difference in calcium retention between groups
No change in blood biomarkers of bone mineral
status (i.e., 25-OH vitamin D, parathyroid
hormone, insulin-like growth factor-I.
Kreijkamp-Kaspers et al., 2004 [119]
Randomised, double-blind, controlled parallel
intervention design
Soy protein supplement (n = 88) vs. milk protein
supplement (n = 87)
12 months, healthy postmenopausal F (66 ± 5 years)
Soy protein—25.6 g protein
Milk protein—25.6 g protein
Single daily ingestion
Hip and lumbar spine bone
mineral density (BMD), plasma
lipid profiles
No difference in BMD from supplementation
No change in plasma lipid profiles
Alekel et al., 2000 [116]
Randomised, double-blind, controlled parallel
intervention design
Isoflavone-rich soy protein (n = 24) vs. isoflavone-poor
soy protein (n = 24) vs. whey protein control (n = 21)
24 weeks supplementation
postmenopausal F (42–62 years, mean 50 years)
All groups 40 g protein/d,
160 mg calcium/d
Isoflavone-rich 80.4 mg aglycone
Isoflavone-poor 4.4 g aglycone
Single daily 500 kcal muffin (20 g protein)
as a meal replacement
Lumbar spine BMD and bone
mineral content (BMC)
Both soy protein groups did not significantly
decrease BMD, whereas the whey control
group did
BMC increase in the isoflavone-rich soy group and
decreased in the whey protein control group.
Liu et al., 2010 [120]
Randomised, double-blind, controlled parallel
intervention design
Soy protein + isoflavone
whey protein + isoflavone
whey protein control
6 months
postmenopausal F (56.1 ± 4.3 years, mean ± SD)
Soy protein—15 g, 100 mg isoflavone




Soy protein with isoflavone supplementation
demonstrated small but significant improvements
in body weight, body mass index and body
fat percentage
Abbreviations: BMC, bone mineral content; BMD, bone mineral density; F, females; SD, standard deviation.
Nutrients 2020, 12, 2670 19 of 35
4. Collagen-Derived Proteins: Effects in Relation to Age, Exercise, Energy Restriction and Source
4.1. Skeletal Muscle
Collagen proteins are the most abundant proteins in the human body [121], accounting for
~25–30% of total protein body mass [26], and are the major constituents of many tissues, including
connective tissue, tendons, ligaments and bones [122]. Thus, dietary collagen is likely a key mediator
of musculoskeletal remodelling throughout the lifespan. As such, collagen supplementation, in the
form of collagen hydrolysates or gelatin, has recently gained popularity as an alternative or adjunct
protein source to animal- and/or plant-derived sources for maintaining or even potentiating muscle
and/or bone health (i.e., mass/function). This may seem counterintuitive since dietary collagen is rich
in non-essential amino acids (NEAA’s; e.g., proline, glycine), low in EAA’s (e.g., methionine, leucine)
and lacks tryptophan, rendering a DIAAS of 0 [27]. Expectedly, this has led to some questioning the
anabolic potential of dietary collagen, at least compared to high-quality protein sources such as whey
protein, which contain high levels of leucine and have a DIAAS of >1 [123]. Nevertheless, pre-clinical
models have shown collagen-specific peptides to offset disease-induced muscle wasting [124], inhibit
age-related muscle oxidative decline [125] and promote muscle hypertrophy via increased mTOR
signalling [122], therein demonstrating the anabolic potential of supplemental collagen-derived
proteins. This, coupled with the fact that dietary collagen has superb digestibility and becomes rapidly
bioavailable following consumption in humans [28,126], suggests that there is potential for dietary
collagen to mediate human skeletal muscle and bone remodelling. However, to date, the effects of
collagen supplementation on muscle health across age, in the absence of allied exercise, has been
sparsely studied.
In regard to ageing, older females consuming the RDA of protein with collagen constituting
approximately half of the total protein provided, preserved lean body mass and maintained nitrogen
balance [127]. In contrast, those consuming a similar quantity of whey protein experienced a loss in
body weight with no change in body fat (potentially indicating a decline in lean body mass) and an
increase in nitrogen excretion [127]. Despite collagen being regarded as a low-quality protein (according
to PDCAAS and DIAAS scores), the NEAA’s it does contain either have a low molecular weight or
possess more than one nitrogen atom (e.g., hydroxyproline, hydroxylysine), meaning the nitrogen
content of collagen on a per gram basis is high [8], and possibly greater than whey protein [127], which
may explain the ability of collagen to help maintain nitrogen balance.
The ability of collagen supplementation to potentiate exercise-induced muscle adaptations is more
widely studied than the effects of collagen supplementation alone yet remains contentious with mixed
results depending on the outcome measure. In regards to body composition, Kirmse et al. [128] observed
an increase in fat-free mass after 12 weeks of RET plus 15 g/d collagen peptide supplementation,
which was not observed in the placebo group. However, similar changes in cross-sectional area and
muscle thickness across the whole cohort (i.e., both groups) suggest that greater myofiber hypertrophy
cannot explain these changes. Other data shows blunted RE-induced increases in anabolic signalling
(p70S6K) (collagen vs. whey protein) [129] and muscle sub-fraction (myofibrillar and sarcoplasmic)
MPS (collagen vs. α-lactalbumin) [130], with collagen protein, albeit in the context of short-term
(3-days) aerobic exercise. The lack of tryptophan and low methionine and leucine content [27] in dietary
collagen may explain the non-hypertrophic responses when used in an unblended fashion (i.e., when
not blended with other dietary protein sources). Instead, it has been suggested that increased connective
tissue/extracellular matrix (ECM) remodelling may contribute to the favourable changes in fat-free mass
that are observed [128]. This supposition is supported by data showing that gelatin supplementation
increased collagen content in engineered ligaments [126]. Similar mechanisms may also underlie
muscle functional responses, specifically muscle strength, where studies have shown collagen peptide
supplements to have no effect on maximal voluntary contraction [29,128], but did speed-up recovery
of countermovement jump performance following strenuous exercise [29]. Since ECM degradation can
occur following exercise [131], it is plausible that the purported collagen-induced ECM remodelling
Nutrients 2020, 12, 2670 20 of 35
(e.g., increased collagen synthesis) occurred, therein improving fast/reactive movements that have
a heavy tendon component (i.e., countermovement jump) [128]. Further, the ability of collagen
supplementation to facilitate the recovery of additional exercise performance measures, such as
maximal voluntary contraction, following an intense period of short-term RET was similar to that of
whey protein [132].
In the context of exercise and ageing, Zdzieblik et al. found that RET for 12 weeks combined
with 15 g/d collagen peptide supplementation led to substantial increases in fat-free mass (+4.2 kg)
and decreases in fat mass (−5.5 kg) in sarcopenic males [26]. However, similar intervention studies
using potent and established nutritional (e.g., animal-derived protein [5]) and pharmacological
(e.g., testosterone [133]) stimulators of muscle growth did not observe such marked increases in
fat-free mass [134], leading some to question the findings of Zdzieblik et al. [134]. More recently,
Jendricke et al. [135] also reported greater increases in fat-free mass and a greater decrease in fat
mass following dietary collagen supplementation, supporting positive body composition changes in
response to this form of supplement. In the absence of known mechanisms, it has been suggested that
a reduction in adipocyte size may contribute to changes in fat mass [121], in addition to the already
mentioned hypothesis of ECM adaptations contributing to fat-free mass gains. That said, collagen
peptide supplementation in older females did not increase rates of integrated collagen (or myofibrillar)
MPS above baseline or in response to two bouts of RE [27], contradicting the suggestion of impacts on
ECM remodelling (at least in older females). Zdzieblik et al. [26] also proposed that collagen-induced
creatine synthesis may underlie changes in fat-free mass, yet daily provision of arginine and glycine
from collagen is small, and thus this has been refuted as a potential mechanism [134]. Collagen
supplementation has also been tested in the context of blood flow restriction, an exercise modality
shown to induce favourable changes in muscle mass in the context of low-intensity RET (~20–30% of 1
repetition maximum) [136,137]. In older males, collagen hydrolysate supplementation for 8 weeks
adjunct to low-load blood flow restriction RET tended to increase muscle cross-sectional area (+6.7%)
more than placebo (+5.7%). Although this was only reported as a trend (i.e., non-significant), this is
likely due to the low participant numbers (n = 11 in each collagen and placebo group), and thus further
studies are required to substantiate these findings.
In the only study of its kind (to date) involving collagen supplementation, energy restriction
(500 kcal/d reduction) and subsequent energy restriction plus activity reduction led to incremental
declines in myofibrillar MPS, which increased during return to habitual activity when supplemented
(throughout) with 30 g whey protein but not with isonitrogenous and isoenergetic collagen protein [77].
In the same study, both energy and energy plus physical activity restrictions (≤750 steps/d) led to
reduced lean body mass and leg lean mass, neither of which were mitigated with either collagen
or whey protein supplementation, despite protein consumption amounting to twice the RDA for
protein [77].
To summarise, dietary collagen does not appear to stimulate MPS in the context of ageing and/or
exercise. However, there is evidence to suggest that it can promote favourable body composition and
muscle functional adaptations when combined with exercise, independent of age, possibly mediated
by ECM remodelling. It is therefore plausible that collagen protein provided simultaneously with
nutritional stimulators of myofiber hypertrophy (i.e., animal/plant protein sources), may maintain
and/or potentiate muscle health via dual mechanisms targeting both ECM and myofiber remodelling
(Table 5).
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Table 5. Collagen-derived proteins: effects on muscle in relation to age, exercise, energy restriction and source.
Reference Study Design Protein Composition Measurements Key Outcomes
Oikawa et al., 2020 [27]
Double-blind, parallel group, randomised controlled trial (RCT)
within-subject design (unilateral leg—rest, contralateral
leg—resistance exercise (RE))
22 healthy older female (F) (n = 11/group, 69 ± 3 years,
mean ± standard deviation (SD))
Randomised to collagen protein or whey protein 2 ×/d for 6 d and
unilateral RE twice during 6 d period
Collagen protein—30 g amino acids (AA)
of hydrolysed collagen protein
Whey protein—30 g AA of whey
protein isolate
(breakdown of AA composition within
each supplement can be found in
original article)
Myofibrillar and collagen
protein synthesis, cell signalling,
baseline body composition
and strength
Plasma leucine concentrations increased above baseline
post whey protein, but not collagen peptide
supplementation
Myofibrillar muscle protein synthesis (MPS) increased at
rest and post-RE following whey protein, but only
increased post-RE following collagen peptide
supplementation
Collagen peptide supplementation did not influence
integrated myofibrillar MPS
Rates of integrated myofibrillar MPS significantly greater
in whey protein than collagen peptide supplementation
Kirmse et al., 2019 [128]
(uses data set from
Oertzen-Hagemann et al., 2019)
Randomised, double-blind, placebo-controlled design
57 moderately trained males (M) (24 ± 3 years, mean ± SD) were
randomised to full-body resistance exercise training (RET)
3 ×/week for 12 weeks and collagen peptide (n = 29) or
placebo (n = 28)
Supplements taken daily for 12 weeks
Hydrolysed collagen peptide—15 g/d
Placebo—15 g/d noncaloric silicon dioxide
Body composition, muscle
thickness, strength, muscle fibre
cross sectional area (CSA),
dietary analysis
Strength and type II CSA increased in both groups
Fat free mass (FFM) significantly increased in the collagen
peptide group, not placebo
Body fat mass (FM) did not change in the collagen peptide
group but increase in the placebo group
No difference in macronutrient intake between groups
Protein intake was 1.81 ± 0.42 and 1.74 ± 0.5 g/kg/day in
collagen and placebo groups, respectively
Zdzieblik et al., 2015 [26]
Randomised, double-blind, placebo-controlled design
53 older (72.2 ± 4.68 years, mean ± SD) sarcopenic M randomised
to full body RET 3 ×/week for 12 weeks and collagen peptide
(n = 26) or placebo (n = 27)
Supplements taken daily for 12 weeks
Collagen peptide—15 g/d
Placebo—15 g/d silicon dioxide
(breakdown of AA composition within




Increase in FFM and strength greater in collagen peptide
versus placebo group
Decrease in FM was greater in collagen peptide versus
placebo group
No difference in dietary intake between groups pre or post
intervention and neither were protein deficient
Jendricke et al., 2019 [135]
Randomised, double-blind, placebo-controlled design
77 premenopausal untrained F were randomised to full body RET
3 ×/week for 12 weeks and collagen peptide
(n = 40, 38.3 ± 8.7 years) or placebo (n = 37, 41.6 ± 6.9 years)
(mean ± SD)
Supplements taken daily for 12 weeks
Collagen peptide—15 g/d
Placebo—15 g/d noncaloric silicon dioxide Body composition, strength
Increase in FFM and hand grip strength was higher in
collagen peptide versus placebo group
Decrease in percentage body fat was greater in collagen
peptide versus placebo group
Oertzen-Hagemann et al., 2019 [28]
Randomised, double-blind, placebo-controlled design
25 M (24.2 ± 2.6 years, mean ± SD) were randomised to full body
RET 3 ×/week for 12 weeks and collagen peptide
(n = 12) or placebo (n = 13)
Supplements taken daily for 12 weeks
Hydrolysed collagen peptide—15 g/d
Placebo—15 g/d noncaloric silicon dioxide
Body composition,
strength, proteome
Collagen peptide is bioactive, demonstrated by increased
circulating levels of hydroxyproline 2 h following collagen
peptide ingestion
Body mass and FFM higher in collagen peptide group
versus placebo
221 higher abundant proteins identified in collagen
peptide group versus on 44 in placebo (proteomic analysis)
Upregulated proteins in the collagen peptide group mostly
associated with protein metabolism of contractile fibres
Hays et al., 2009 [127]
Double-blind, randomised, cross-over design
9 healthy F (71 ± 1 years, mean ± standard error of the mean
(SEM)) completed 2 × 15 d trials (7 d wash-out period in between)
Each trial consisted of consuming 0.8 g protein/kg body weight/d
with either whey protein or collagen peptide intended to provide
~0.4 g/kg body weight/d
Hydrolysed collagen peptide—~0.4 g/kg
body weight/d
Whey protein—~0.4 g/kg body weight/d
Body composition, nitrogen
balance, dietary analysis
Body weight decreased after whey but not collagen
protein intake
Nitrogen excretion was higher during whey versus
collagen protein intake
No difference in macronutrient intake between collagen
peptide and whey protein groups (protein intake was
0.82 ± 0.04 g/kg/d)
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Table 5. Cont.
Reference Study Design Protein Composition Measurements Key Outcomes
Oikawa et al., 2018 [77]
Double-blind, parallel group, RCT
16 M (69 ± 3 years) and 15 F (68 ± 4 years) were randomised to
collagen peptide (n = 15) or whey protein (n = 16) and completed
4 phases:
1. 1-week energy balance
2. 1-week energy restriction (−500 kcal/d) and protein
supplementation (1.6.g protein/kg/d with 45 ± 9% from whey
protein (30 g 2 ×/d) or collagen peptide (30 g 2 ×/d))
3. 2-week energy restriction with step reduction (≤750 steps/d)
4. 1-week habitual activity (continuing the high protein
supplementation protocol)
(mean ± SD)
Hydrolysed collagen peptide—30 g
Whey protein isolate—30 g
(breakdown of AA composition within





Protein supplementation (whey protein or collagen
peptide) did not prevent leg LM loss during energy
restriction and energy restriction with step reduction
Whey protein, but not collagen peptide, augmented lean
body mass, leg LM and MPS during habitual activity
MPS remained suppressed during the energy restriction
with step reduction and habitual activity phases in the
collagen peptide group
Impey et al., 2018 [129]
Repeated-measures, counterbalanced design
7–9 d wash-out period
8 recreational M cyclists (25 ± 3 years, mean ± SD) completed an
exercise trial in conditions of reduced carbohydrate with
hydrolysed collagen or whey protein consumed before, during
and after exercise
Hydrolysed collagen blend—22 g (66 g
total) taken pre, during and post-exercise




No effect of hydrolysed collagen (or whey protein) on
markers of muscle mitochondrial adaptations
Hydrolysed collagen supplementation increased anabolic
signalling but to a lesser extent than whey protein
Clifford et al., 2019 [29]
Double-blind, placebo-controlled, independent group design
24 recreationally active M were randomised to collagen peptide
(n = 12, 24.1 ± 4.3 years) or placebo (n = 12, 24.8 ± 4.8 years)







Countermovement jump recovered quicker following
collagen peptide supplementation (versus placebo)
No difference in macronutrient intake between groups
throughout the study
Protein intake was 1.26 ± 0.46 and 1.18 ± 0.27 g/kg/bm−1
for collagen peptide and placebo groups, respectively.
Rindom et al., 2016 [132]
Double-blind, randomised, cross-over design
12 young M (24.6 ± 2.1 years, mean ± SD) completed 1 week of
intense full-body RET (4 RET sessions) whilst consuming
collagen protein or whey protein, followed by 3 weeks recovery,
then completed another 1-week period of intense RET whilst
consuming collagen or whey protein (opposite to the type
ingested during the first week)
Collagen protein—20 g/d
Whey protein—20 g/d
During the intense RET period, all
volunteers received 1.4 g protein/kg
bodyweight in addition to the study
supplement (i.e., whey/collagen protein)
Muscle function
48 h after the final exercise bout, maximal voluntary
contraction had returned to baseline in both groups. No
difference was noted between whey or collagen protein
groups at any timepoint
48 h after the final exercise bout, counter movement jump
(CMJ) height had returned to baseline in the collagen
protein, but not whey protein, supplemented group
3 h after the final exercise bout, whey protein
supplemented group displayed attenuated losses in CMJ
compared to collagen protein
Oikawa et al., 2019 [130]
Double-blind, randomised, cross-over design
4 d wash-out
11 endurance trained adults (M n = 5, F n = 6, 24 ± 4 years, mean
± SD) engaged in daily high-intensity interval training with
hydrolysed collagen or α-lactalbumin supplementation for 3 d
Hydrolysed collagen peptides—60 g/d
α-lactalbumin—60 g/d
(breakdown of AA composition within




Plasma leucine and tryptophan concentrations were
greater following α-lactalbumin compared to hydrolysed
collagen supplementation
Exercise-induced increased in myofibrillar and
sarcoplasmic MPS were greater with α-lactalbumin
compared to hydrolysed collagen supplementation
No differences in macronutrient intake between groups
Centner et al., 2019 [137]
Prospective, randomised, placebo-controlled design
Older M randomised to 8 weeks blood flow resistance (BFR)
training with collagen hydrolysate (n = 11, 61.7 ± 5.5 years) or
8 weeks BFR training with placebo (n = 11, 56.6 ± 6.1 years) or no
training with collagen hydrolysate (control)
(n = 8, 62.5 ± 10.5 years)
(mean ± SD)
Collagen hydrolysate—15 g/d
Placebo—silicon dioxide—15 g/d CSA and muscle function
Muscle CSA increase in BFR-collagen hydrolysate
(+6.7% ± 3.2%) and BFR-placebo (+5.7% ± 2.7%) but not
in control
1-repition maximum strength increased in BRF-collagen
hydrolysate (+10.2% ± 24.8%), and BFR-placebo
(+4.8% ± 11.4%) but not control, relative to
pre-study levels
Abbreviations: AA, amino acid; BFR, blood flow restriction; counter movement jump, CMJ; CSA, cross-sectional area; F, females; FFM, fat-free mass; FM, fat mass; M, males; MPS, muscle
protein synthesis; RCT, randomised controlled trial; RE, resistance exercise; RET, resistance exercise training; SD, standard deviation; SEM, standard error of the mean.
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4.2. Bone
The anabolic effects of collagen supplementation on bone health have been recognised in
pre-clinical models demonstrating enhanced bone metabolism [138], microarchitecture [139] and
offsetting age-related bone density decline [125], although the effects in humans are less well understood.
In the context of ageing, post-menopausal females supplemented with 5 g/d calcium-collagen chelate
(albeit with 500 mg calcium and 200 IU vitamin D3) for 12 months had attenuated whole-body BMD
losses compared to control (calcium and vitamin D3) [140]. Whilst these positive effects cannot
necessarily be attributed purely to collagen supplementation due to insufficient dietary control, these
findings were later echoed by a 12-month randomised, double-blind, placebo-controlled trial, in which
postmenopausal females given 5 g/d collagen peptide demonstrated significant increases in BMD of the
femoral neck and lumbar spine and an increase in P1NP, indicative of an increase in bone formation [141].
Expectedly, the control group (5 g/d maltodextrin) displayed numerical (non-significant) declines
in BMD and increases in CTX, indicative of bone degradation over the intervention period [141].
Since there were no differences in macro- or micro-nutrient intake observed between the treatment
and control groups pre- or post-intervention, this may indicate that the positive effects on BMD are
attributable to collagen supplementation.
In the context of exercise, it is thought that the liberation of collagen-specific AA (e.g., glycine,
proline) from dietary collagen may potentiate exercise-induced collagen synthesis, therein facilitating
bone remodelling. This hypothesis is somewhat supported by data from Shaw et al. [126], who found
that supplementation with 5 g of vitamin-C (48 mg)-enriched gelatin (denatured form of collagen [122])
prior to intermittent high-impact exercise in young males increased circulating P1NP, indicative of
increased bone collagen synthesis. Outwardly, this makes sense as vitamin-C is a cofactor for the
enzymes lysyl hydroxylase and prolyl hydroxylase, which are essential for collagen synthesis [142].
In the absence of vitamin-C, 20 g/d collagen supplementation before and after strenuous exercise in
young males had no significant effects on P1NP or β-isomerised CTX [29], suggesting that collagen
alone does not support bone collagen synthesis. The discrepant findings between these studies may
be due to the vitamin-C content or based on other methodological differences such as the differing
collagen source (i.e., collagen peptide vs. gelatin) and/or amount (i.e., 20 g/d vs. 15 g/d vs. 5 g/d) of
collagen provided.
The effects of collagen supplementation in tandem with chronic exercise training on bone health
are not yet well established. In older sarcopenic males, 6 weeks of RET with 15 g/d collagen peptide
supplementation did not augment RET-induced gains in bone mass [26], although the authors do
not speculate about the reason for this lack of effect. Since one year of collagen supplementation
alone (i.e., in the absence of RET) did improve BMD in older adults [141], it is conceivable that the
supplementation period was too short to elicit collagen-induced effects in the slow turnover tissue
that is bone.
Overall, dietary collagen appears to offer benefits to bone health in terms of offsetting age-related
bone loss, potentially mediated by increasing bone formation and decreasing bone degradation.
However, the synergistic effects of collagen supplementation and exercise remain contentious (Table 6).
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Table 6. Collagen-derived proteins: effects on bone in relation to age, exercise, energy restriction and source.
Reference Study Design Protein Composition Measurements Key Outcomes
Zdzieblik et al., 2015 [26] (also
studied effects on muscle, see Table 5)
Randomised, double-blind, placebo-controlled design
53 older (72.2 ± 4.68 years, mean ± standard deviation
(SD)) sarcopenic males (M) randomised to full body
resistance exercise training (RET) 3 ×/week for 12 weeks
and collagen peptide (n = 26) or placebo (n = 27)
Supplements taken daily for 12 weeks
Collagen peptide—15 g/d
Placebo—15 g/d silicon dioxide
(breakdown of amino acid composition
within collagen peptide supplement can
be found in original article)
Bone mass, dietary analysis
No potentiating effect of collagen peptide on bone mass
(beyond that of RET alone)
No difference in dietary intake between groups pre- or
post-intervention and neither were protein deficient
Clifford et al., 2019 [29] (also studied
effects on muscle, see table above)
Double-blind, placebo-controlled, independent
group design
24 recreationally active M were randomised to collagen
peptide (n = 12, 24.1 ± 4.3 years) or placebo
(n = 2, 24.8 ± 4.8 years) supplementation 7 d before and
2 d after exercise
(mean ± SD)
Collagen peptide—20 g/d Isoenergetic
and isovolumic placebo—20 g/d
Bone turnover markers,
dietary analysis
Collagen peptide had no effect on markers of bone turnover
No difference in macronutrient intake between groups
throughout the study
No difference in macronutrient intake between collagen
peptide and placebo groups.
Protein intake was 1.26 ± 0.46 and 1.18 ± 0.27 g/kg/bm−1 for
collagen peptide and placebo groups, respectively
König et al., 2018 [141]
Randomised, double-blind, placebo-controlled design
Postmenopausal females (F) randomised to collagen
peptide (n = 66, 63.8 ± 7.4 years) or placebo




Bone mineral density (BMD), bone
turnover markers, dietary analysis
BMD increased following collagen peptide supplementation
(no change in placebo)
Amino-terminal propeptide of collagen I (P1NP) increased
following collagen peptide supplementation
C-terminal telopeptide of collagen type-I increased
following placebo supplementation
No difference in macro or micronutrient intake between the
groups pre or post intervention and neither were
protein deficient
Shaw et al., 2017 [126]
Double-blind, randomised, cross-over design
4 d washout period
8 healthy recreationally active M (27 ± 6 years,
mean ± standard error of the mean) provided placebo, 5
or 15 g vitamin-C-enriched gelatin and completed rope
skipping exercise, 3 ×/d for 3 days
5 g vitamin-C (48 mg)-enriched gelatin
15 g vitamin-C (48 mg)-enriched gelatin
Maltodextrin (placebo)—weight and
calorie matched
Bone turnover marker 15 g vitamin-C-enriched gelatin increased circulating P1NPmore so than placebo and 5 g
Elam et al., 2014 [140]
Randomised, double-blind, placebo-controlled design
39 postmenopausal F (55.7 ± 3.3 years, mean ± SD)
randomised to daily hydrolysed calcium-collagen
chelate or placebo supplementation for 12 months
Hydrolysed calcium-collagen
chelate—5 g/d (with 500 mg elemental
calcium, 200 IU vitamin D3)
Control—500 mg elemental calcium,
200 IU vitamin D3
Total body, lumbar and hip BMD,
bone turnover markers
Loss of total body BMD was lower following 12 months
supplementation of hydrolysed calcium-collagen chelate
versus control (n = 22 at 12 months follow up)
Sclerostin and tartrate-resistant acid phosphatase isoform 5b
(TRAP5b) were lower and bone-specific alkaline
phosphatase/TRAP5b ratio was higher following 6 months
supplementation of hydrolysed calcium-collagen chelate
versus control
Abbreviations: BMD, bone mineral density; F, females; M, males; P1NP, amino-terminal propeptide of collagen I; RET, resistance exercise training; SD, standard deviation; TRAP5b,
tartrate-resistant acid phosphatase isoform 5b.
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5. Animal-, Plant- and/or Collagen-Derived Protein Blends
Protein blends offer a potentially viable and sustainable option to compensate for EAA deficiencies
in some protein sources, thereby overcoming the inferior anabolic profiles of plant- and collagen-,
versus animal-derived protein. Most research to date has assessed the effects of animal and plant blends
in the context of skeletal muscle health, where the combination may exploit the digestive properties
of each protein source, maximising AA availability and potentially extending and augmenting the
MPS response [9]. For example, a protein blend containing 25% whey protein, 25% soy protein and
50% casein protein provided after acute RE in young healthy males stimulated mixed MPS in a similar
fashion to whey protein [30]. Considering both supplements provided similar amounts of EAA and
leucine, the similar anabolic stimulus is unsurprising and thus provides evidence to support the
use of plant-derived proteins to promote acute muscle anabolism alongside animal-derived sources.
This similar anabolic response to animal and plant blends (versus whey protein) also holds true in
older adults [32]. However, it should be noted that in both of these studies, only 25% of the protein
blend was plant-derived, and since plant-derived protein contains lower leucine and less EAA, the
consumption of protein blends with higher percentages of plant-derived sources may not be as effective
for stimulating muscle anabolism, particularly in older adults who display anabolic resistance [7,55],
although this remains to be determined. Current evidence in regard to protein blends × exercise
interactions is sparse, however, daily supplementation of a soy and dairy protein blend (containing
25% whey protein, 25% soy protein and 50% casein protein) during whole-body RET for 12 weeks
tended to increase lean body mass compared to maltodextrin control, with no trend observed in a
whey protein supplemented group [31]. Whilst this may be a reflection of the beneficial divergent
digestive properties of these protein sources, further research is required to confirm or refute this.
Although the consumption of animal and plant protein-blends may be suitable for some, they will
not be suitable for all (i.e., vegans) and as such, sustainable plant- and plant-derived protein blends
(i.e., blending two or more different plant protein sources) are an emerging area of interest and research.
Whilst there is no experimental evidence available to date, it is plausible that combining a plant-derived
protein source low in lysine and high in methionine (e.g., rice) with another plant-derived protein
source with a divergent EAA profile (e.g., pea protein) will provide a plant protein blend that satisfies
all of the EAA necessary for robustly stimulating MPS [7,9]. Indeed, researchers have started to develop
a variety of mixed plant-protein blends that exceed current AA requirements [9]. However, whether
these blends stimulate MPS similarly to animal-derived proteins remains to be seen [9]. Further, the
efficacy of plant and collagen protein blends for muscle health (both with and without animal-derived
protein) warrants future research, particularly since collagen may support ECM remodelling and thus
may be particularly effective in the context of acute/chronic exercise.
In summary, the limited available evidence suggests that animal and plant protein blends may
support anabolic responses to acute exercise.
6. Future Directions
Despite a wealth of protein source research to date, many gaps remain in our understanding of
how animal, plant, collagen and blended protein sources can modulate musculoskeletal outcomes,
particularly in the context of ageing, exercise and energy restriction. Here, we outline some of the key
gaps that we suggest are worthy of imminent future investigation.
Whilst animal-derived protein sources are by far the most investigated protein source to date,
the length of time that the muscle remains refractory to dietary animal-derived protein following
the onset of “muscle full” remains to be determined. Whether the kinetics of this refractory period
(e.g., duration) are dependent on the protein source (i.e., plant, collagen, blended) also remains to be
investigated thoroughly. Further, whilst much research has investigated the optimal (e.g., amount,
type, etc.) animal-derived protein feeding strategy, the optimal type, texture, matrix and amount
of animal protein that is most beneficial for maintaining and potentiating musculoskeletal health
(i.e., muscle and bone) during energy restriction remains to be fully investigated.
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Similarly, there is a lack of rigorous experimental findings in regard to the effects of
plant-derived protein sources on both muscle and bone health during energy restriction, warranting
further investigation.
In regard to collagen protein, further research should look to substantiate previous evidence
suggesting that collagen protein may support blood flow restriction RET-induced muscle growth.
In the context of bone health, collagen protein provided in conjunction with vitamin-C may herald
anabolic bone remodelling effects, although this remains to be investigated. Since much less research
exists regarding collagen protein (compared with animal- and plant-derived protein), much more work
is needed to determine the optimal collagen protein dosing strategy (e.g., amount, timing), including
adjuvant nutritional needs (i.e., vitamin-C, protein blends), that is most beneficial for potentiating
muscle and bone health, particularly in the context of exercise and energy restriction.
Finally, whilst there is evidence to suggest that protein blends may support musculoskeletal
remodelling in response to acute exercise, further evidence is required to clarify the effects in regard to
supporting chronic RET-induced musculoskeletal adaptations. Theoretically, mixed plant, plant and
collagen, animal and collagen, and animal and plant blends each have anabolic potential, however,
the most sustainable and efficacious protein blend for anabolic stimulation in the context of exercise,
ageing and energy restriction remains to be determined.
7. Conclusions
In conclusion, an increased appreciation of the role of protein sources (including protein blends)
in relation to the musculoskeletal system under beneficial (e.g., exercise) and deleterious (e.g., ageing,
energy restriction) perturbations is crucial to informing appropriate nutritional support in the face of
complex challenges, such as changes in appetite and/or socio-economic trends. Plant-derived proteins
may provide suitable alternatives to animal proteins in relation to musculoskeletal health, albeit
under some circumstances at higher-intakes. Similarly, collagen-derived proteins represent relatively
nitrogen-dense sources that have shown some efficacy in relation to favourable body composition
changes. Protein blends harnessing the biological benefits of distinct protein sources may represent
a means by which to maximise the health benefits of dietary proteins in relation to musculoskeletal
health. A schematic representation of this conclusion is presented in Figure 1.
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Figure 1. Summary of the key musculoskeletal benefits of animal, plant, collagen and blended dietary
proteins. Abbreviations: ALP, alkaline phosphatase; BC, body composition; BMC, bone mineral content;
BMD, bone mineral density; CMJ, counter movement jump; EAA, essential amino acids; FFM, fat free
mass; IGF-1, insulin-like growth factor 1; MPS, muscle protein synthesis; mTOR, mechanistic target of
rapamycin; MVC, maximal voluntary contraction; P1NP, amino-terminal propeptide of collagen I.
Nutrients 2020, 12, 2670 27 of 35
Author Contributions: C.S.D., J.J.B., H.C., B.E.P. and P.J.A. completed the literature searches, review and drafted
the manuscript. C.S.D., J.J.B., H.C., B.E.P. and P.J.A. reviewed, edited and approved the manuscript for its
intellectual content. All authors have read and agreed to the published version of the manuscript.
Funding: This research was supported by the MRC Versus Arthritis Centre for Musculoskeletal Ageing Research
(grant numbers MR/P021220/1 and MR/R502364/1) and National Institute for Health Research Nottingham
Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS,
the NIHR or the Department of Health and Social Care. C.S.D. is a Medical Research Council Skills Development
Fellow (MR/T026014/1).
Conflicts of Interest: P.J.A. has acted in a consultant role to Fresenius Kabi.
References
1. Bradlee, M.L.; Mustafa, J.; Singer, M.R.; Moore, L.L. High-protein foods and physical activity protect against
age-related muscle loss and functional decline. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2018, 73, 88–94.
[CrossRef] [PubMed]
2. Dawson-Hughes, B.; Harris, S.S. Calcium intake influences the association of protein intake with rates of
bone loss in elderly men and women. Am. J. Clin. Nutr. 2002, 75, 773–779. [CrossRef] [PubMed]
3. Bowen, J.; Noakes, M.; Clifton, P.M. A high dairy protein, high-calcium diet minimizes bone turnover in
overweight adults during weight loss. J. Nutr. 2004, 134, 568–573. [CrossRef] [PubMed]
4. Hector, A.J.; Marcotte, G.R.; Churchward-Venne, T.A.; Murphy, C.H.; Breen, L.; von Allmen, M.; Baker, S.K.;
Phillips, S.M. Whey protein supplementation preserves postprandial myofibrillar protein synthesis during
short-term energy restriction in overweight and obese adults. J. Nutr. 2015, 145, 246–252. [CrossRef]
[PubMed]
5. Cermak, N.M.; Res, P.T.; de Groot, L.C.P.G.M.; Saris, W.H.M.; van Loon, L.J.C. Protein supplementation
augments the adaptive response of skeletal muscle to resistance-type exercise training: A meta-analysis.
Am. J. Clin. Nutr. 2012, 96, 1454–1464. [CrossRef]
6. Pimentel, D.; Pimentel, M. Sustainability of meat-based and plant-based diets and the environment. Am. J.
Clin. Nutr. 2003, 78, 660–663. [CrossRef]
7. van Vliet, S.; Burd, N.A.; van Loon, L.J. The skeletal muscle anabolic response to plant- versus animal-based
protein consumption. J. Nutr. 2015, 145, 1981–1991. [CrossRef]
8. Castellanos, V.H.; Litchford, M.D.; Campbell, W.W. Modular protein supplements and their application to
long-term care. Nutr. Clin. Pract. 2006, 21, 485–504. [CrossRef]
9. Gorissen, S.H.M.; Witard, O.C. Characterising the muscle anabolic potential of dairy, meat and plant-based
protein sources in older adults. Proc. Nutr. Soc. 2018, 77, 20–31. [CrossRef]
10. Turkiewicz, M. Collagen hydrolysates as a new diet supplement. Sci. Bull. Tech. Univ. Lodz 2009, 73, 83–92.
11. Etheridge, T.; Oczypok, E.A.; Lehmann, S.; Fields, B.D.; Shephard, F.; Jacobson, L.A.; Szewczyk, N.J. Calpains
mediate integrin attachment complex maintenance of adult muscle in Caenorhabditis elegans. PLoS Genet.
2012, 8. [CrossRef] [PubMed]
12. Demontiero, O.; Vidal, C.; Duque, G. Aging and bone loss: New insights for the clinician. Ther. Adv.
Musculoskelet. Dis. 2012, 4, 61–76. [CrossRef] [PubMed]
13. Henry, Y.M.; Fatayerji, D.; Eastell, R. Attainment of peak bone mass at the lumbar spine, femoral neck
and radius in men and women: Relative contributions of bone size and volumetric bone mineral density.
Osteoporos. Int. 2004, 15, 263–273. [CrossRef] [PubMed]
14. Wilkinson, D.J.; Hossain, T.; Hill, D.S.; Phillips, B.E.; Crossland, H.; Williams, J.; Loughna, P.;
Churchward-Venne, T.A.; Breen, L.; Phillips, S.M.; et al. Effects of leucine and its metabolite
β-hydroxy-β-methylbutyrate on human skeletal muscle protein metabolism. J. Physiol. 2013, 591, 2911–2923.
[CrossRef] [PubMed]
15. Heaney, R.P.; Layman, D.K. Amount and type of protein influences bone health. Am. J. Clin. Nutr. 2008, 87,
1567–1570. [CrossRef] [PubMed]
16. Layman, D.K.; Anthony, T.G.; Rasmussen, B.B.; Adams, S.H.; Lynch, C.J.; Brinkworth, G.D.; Davis, T.A.
Defining meal requirements for protein to optimize metabolic roles of amino acids. Am. J. Clin. Nutr. 2015,
101, 1330S–1338S. [CrossRef]
Nutrients 2020, 12, 2670 28 of 35
17. Traylor, D.A.; Gorissen, S.H.M.; Phillips, S.M. Perspective: Protein requirements and optimal intakes in aging:
Arewe ready to recommend more than the recommended daily allowance? Adv. Nutr. 2018, 9, 171–182.
[CrossRef]
18. Deutz, N.E.P.; Bauer, J.M.; Barazzoni, R.; Biolo, G.; Boirie, Y.; Bosy-Westphal, A.; Cederholm, T.;
Cruz-Jentoft, A.; Krznariç, Z.; Nair, K.S.; et al. Protein intake and exercise for optimal muscle function with
aging: Recommendations from the ESPEN Expert Group. Clin. Nutr. 2014, 33, 929–936. [CrossRef]
19. Phillips, S.M.; Chevalier, S.; Leidy, H.J. Protein “requirements” beyond the RDA: Implications for optimizing
health. Appl. Physiol. Nutr. Metab. 2016, 41, 565–572. [CrossRef]
20. Lin, P.H.; Miwa, S.; Li, Y.J.; Wang, Y.; Levy, E.; Lastor, K.; Champagne, C. Factors influencing dietary protein
sources in the PREMIER trial population. J. Am. Diet. Assoc. 2010, 110, 291–295. [CrossRef]
21. O’Neil, C.E.; Keast, D.R.; Fulgoni, V.L.; Nicklas, T.A. Food sources of energy and nutrients among adults in
the US: NHANES 2003–2006. Nutrients 2012, 4, 2097–2120. [CrossRef] [PubMed]
22. Song, M.; Fung, T.T.; Hu, F.B.; Willett, W.C.; Longo, V.D.; Chan, A.T.; Giovannucci, E.L. Association of animal
and plant protein intake with all-cause and cause-specific mortality. JAMA Intern. Med. 2016, 176, 1453–1463.
[CrossRef] [PubMed]
23. Joy, J.M.; Lowery, R.P.; Wilson, J.M.; Purpura, M.; De Souza, E.O.; Wilson, S.M.; Kalman, D.S.; Dudeck, J.E.;
Jäger, R. The effects of 8 weeks of whey or rice protein supplementation on body composition and exercise
performance. Nutr. J. 2013, 12. [CrossRef] [PubMed]
24. Langsetmo, L.; Shikany, J.M.; Cawthon, P.M.; Cauley, J.A.; Taylor, B.C.; Vo, T.N.; Bauer, D.C.; Orwoll, E.S.;
Schousboe, J.T.; Ensrud, K.E. The association between protein intake by source and osteoporotic fracture in
older men: A prospective cohort study. J. Bone Miner. Res. 2017, 32, 592–600. [CrossRef] [PubMed]
25. Langsetmo, L.; Shikany, J.M.; Burghardt, A.J.; Cawthon, P.M.; Orwoll, E.S.; Cauley, J.A.; Taylor, B.C.;
Schousboe, J.T.; Bauer, D.C.; Vo, T.N.; et al. High dairy protein intake is associated with greater bone strength
parameters at the distal radius and tibia in older men: A cross-sectional study. Osteoporos. Int. 2018, 29,
69–77. [CrossRef]
26. Zdzieblik, D.; Oesser, S.; Baumstark, M.W.; Gollhofer, A.; König, D. Collagen peptide supplementation in
combination with resistance training improves body composition and increases muscle strength in elderly
sarcopenic men: A randomised controlled trial. Br. J. Nutr. 2015, 114, 1237–1245. [CrossRef]
27. Oikawa, S.Y.; Kamal, M.J.; Webb, E.K.; McGlory, C.; Baker, S.K.; Phillips, S.M. Whey protein but not collagen
peptides stimulate acute and longer-term muscle protein synthesis with and without resistance exercise in
healthy older women: A randomized controlled trial. Am. J. Clin. Nutr. 2020, 111, 708–718. [CrossRef]
28. Oertzen-Hagemann, V.; Kirmse, M.; Eggers, B.; Pfeiffer, K.; Marcus, K.; de Marées, M.; Platen, P. Effects of 12
weeks of hypertrophy resistance exercise training combined with collagen peptide supplementation on the
skeletal muscle proteome in recreationally active men. Nutrients 2019, 11, 1072. [CrossRef]
29. Clifford, T.; Ventress, M.; Allerton, D.M.; Stansfield, S.; Tang, J.C.Y.; Fraser, W.D.; Vanhoecke, B.; Prawitt, J.;
Stevenson, E. The effects of collagen peptides on muscle damage, inflammation and bone turnover following
exercise: A randomized, controlled trial. Amino Acids 2019, 51, 691–704. [CrossRef]
30. Reidy, P.T.; Walker, D.K.; Dickinson, J.M.; Gundermann, D.M.; Drummond, M.J.; Timmerman, K.L.; Fry, C.S.;
Borack, M.S.; Cope, M.B.; Mukherjea, R.; et al. Protein blend ingestion following resistance exercise promotes
human muscle protein synthesis. J. Nutr. 2013, 143, 410–416. [CrossRef]
31. Reidy, P.T.; Borack, M.S.; Markofski, M.M.; Dickinson, J.M.; Deer, R.R.; Husaini, S.H.; Walker, D.K.; Igbinigie, S.;
Robertson, S.M.; Cope, M.B.; et al. Protein supplementation has minimal effects on muscle adaptations
during resistance exercise training in young men: A double-blind randomized clinical trial. J. Nutr. 2016,
146, 1660–1669. [CrossRef] [PubMed]
32. Borack, M.S.; Reidy, P.T.; Husaini, S.H.; Markofski, M.M.; Deer, R.R.; Richison, A.B.; Lambert, B.S.; Cope, M.B.;
Mukherjea, R.; Jennings, K.; et al. Soy-dairy protein blend or whey protein isolate ingestion induces similar
postexercise muscle mechanistic target of rapamycin complex 1 signaling and protein synthesis responses in
older men. J. Nutr. 2016, 146, 2468–2475. [CrossRef]
33. Mathai, J.K.; Liu, Y.; Stein, H.H. Values for digestible indispensable amino acid scores (DIAAS) for some dairy
and plant proteins may better describe protein quality than values calculated using the concept for protein
digestibility-corrected amino acid scores (PDCAAS). Br. J. Nutr. 2017, 117, 490–499. [CrossRef] [PubMed]
34. Schaafsma, G. The protein digestibility–corrected amino acid score. J. Nutr. 2000, 130, 1865S–1867S. [CrossRef]
[PubMed]
Nutrients 2020, 12, 2670 29 of 35
35. Phillips, S.M. Nutrient-rich meat proteins in offsetting age-related muscle loss. Meat Sci. 2012, 92, 174–178.
[CrossRef]
36. Moughan, P.J. Holistic properties of foods: A changing paradigm in human nutrition. J. Sci. Food Agric. 2018.
[CrossRef]
37. Burd, N.A.; Beals, J.W.; Martinez, I.G.; Salvador, A.F.; Skinner, S.K. Food-first approach to enhance the
regulation of post-exercise skeletal muscle protein synthesis and remodeling. Sport Med. 2019, 49, 59–68.
[CrossRef]
38. Witard, O.C.; Wardle, S.L.; Macnaughton, L.S.; Hodgson, A.B.; Tipton, K.D. Protein considerations for
optimising skeletal muscle mass in healthy young and older adults. Nutrients 2016, 8, 181. [CrossRef]
39. Deane, C.S.; Wilkinson, D.J.; Phillips, B.E.; Smith, K.; Etheridge, T.; Atherton, P.J. “Nutraceuticals” in relation
to human skeletal muscle and exercise. Am. J. Physiol. Endocrinol. Metab. 2017, 312, E282–E299. [CrossRef]
40. Sharples, A.P.; Hughes, D.C.; Deane, C.S.; Saini, A.; Selman, C.; Stewart, C.E. Longevity and skeletal muscle
mass: The role of IGF signalling, the sirtuins, dietary restriction and protein intake. Aging Cell 2015, 14,
511–523. [CrossRef]
41. Symons, T.B.; Sheffield-Moore, M.; Wolfe, R.R.; Paddon-Jones, D. A moderate serving of high-quality protein
maximally stimulates skeletal muscle protein synthesis in young and elderly subjects. J. Am. Diet. Assoc.
2009, 109, 1582–1586. [CrossRef]
42. Smith, K.; Reynolds, N.; Downie, S.; Patel, A.; Rennie, M.J. Effects of flooding amino acids on incorporation
of labeled amino acids into human muscle protein. Am. J. Physiol. Metab. 1998, 275, E73–E78. [CrossRef]
[PubMed]
43. Atherton, P.J.; Smith, K.; Etheridge, T.; Rankin, D.; Rennie, M.J. Distinct anabolic signalling responses to
amino acids in C2C12 skeletal muscle cells. Amino Acids 2010, 38, 1533–1539. [CrossRef]
44. Witard, O.C.; Jackman, S.R.; Breen, L.; Smith, K.; Selby, A.; Tipton, K.D. Myofibrillar muscle protein synthesis
rates subsequent to a meal in response to increasing doses of whey protein at rest and after resistance exercise.
Am. J. Clin. Nutr. 2014, 99, 86–95. [CrossRef] [PubMed]
45. Moore, D.R.; Robinson, M.J.; Fry, J.L.; Tang, J.E.; Glover, E.I.; Wilkinson, S.B.; Prior, T.; Tarnopolsky, M.A.;
Phillips, S.M. Ingested protein dose response of muscle and albumin protein synthesis after resistance
exercise in young men. Am. J. Clin. Nutr. 2009, 89, 161–168. [CrossRef] [PubMed]
46. Cuthbertson, D.; Smith, K.; Babraj, J.; Leese, G.; Waddell, T.; Atherton, P.; Wackerhage, H.; Taylor, P.M.;
Rennie, M.J. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J.
2005, 19, 422–424. [CrossRef] [PubMed]
47. Atherton, P.J.; Smith, K. Muscle protein synthesis in response to nutrition and exercise. J. Physiol. 2012, 590,
1049–1057. [CrossRef]
48. Atherton, P.J.; Etheridge, T.; Watt, P.W.; Wilkinson, D.; Selby, A.; Rankin, D.; Smith, K.; Rennie, M.J. Muscle
full effect after oral protein: Time-dependent concordance and discordance between human muscle protein
synthesis and mTORC1 signaling. Am. J. Clin. Nutr. 2010, 92, 1080–1088. [CrossRef]
49. Alexandrov, N.V.; Eelderink, C.; Singh-Povel, C.M.; Navis, G.J.; Bakker, S.J.L.; Corpeleijn, E. Dietary protein
sources and muscle mass over the life course: The lifelines cohort study. Nutrients 2018, 10, 1471. [CrossRef]
50. Koopman, R.; Walrand, S.; Beelen, M.; Gijsen, A.P.; Kies, A.K.; Boirie, Y.; Saris, W.H.M.; van Loon, L.J.C.
Dietary protein digestion and absorption rates and the subsequent postprandial muscle protein synthetic
response do not differ between young and elderly men. J. Nutr. 2009, 139, 1707–1713. [CrossRef]
51. Symons, T.B.; Schutzler, S.E.; Cocke, T.L.; Chinkes, D.L.; Wolfe, R.R.; Paddon-Jones, D. Aging does not impair
the anabolic response to a protein-rich meal. Am. J. Clin. Nutr. 2007, 86, 451–456. [CrossRef] [PubMed]
52. Moro, T.; Brightwell, C.R.; Deer, R.R.; Graber, T.G.; Galvan, E.; Fry, C.S.; Volpi, E.; Rasmussen, B.B. Muscle
protein anabolic resistance to essential amino acids does not occur in healthy older adults before or after
resistance exercise training. J. Nutr. 2018, 148, 900–909. [CrossRef]
53. Burd, N.A.; Gorissen, S.H.; Van Loon, L.J.C. Anabolic resistance of muscle protein synthesis with aging.
Exerc. Sport Sci. Rev. 2013, 41, 169–173. [CrossRef]
54. Katsanos, C.S.; Kobayashi, H.; Sheffield-Moore, M.; Aarsland, A.; Wolfe, R.R. Aging is associated with
diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am. J.
Clin. Nutr. 2005, 82, 1065–1073. [CrossRef] [PubMed]
Nutrients 2020, 12, 2670 30 of 35
55. Wall, B.T.; Gorissen, S.H.; Pennings, B.; Koopman, R.; Groen, B.B.L.; Verdijk, L.B.; Van Loon, L.J.C. Aging
is accompanied by a blunted muscle protein synthetic response to protein ingestion. PLoS ONE 2015,
10, e0140903. [CrossRef] [PubMed]
56. Boirie, Y.; Gachon, P.; Beaufrère, B. Splanchnic and whole-body leucine kinetics in young and elderly men.
Am. J. Clin. Nutr. 1997, 65, 489–495. [CrossRef]
57. Gorissen, S.H.M.; Rémond, D.; van Loon, L.J.C. The muscle protein synthetic response to food ingestion.
Meat Sci. 2015, 109, 96–100. [CrossRef]
58. Burd, N.A.; Yang, Y.; Moore, D.R.; Tang, J.E.; Tarnopolsky, M.A.; Phillips, S.M. Greater stimulation of
myofibrillar protein synthesis with ingestion of whey protein isolate v. micellar casein at rest and after
resistance exercise in elderly men. Br. J. Nutr. 2012, 108, 958–962. [CrossRef]
59. Pennings, B.; Boirie, Y.; Senden, J.M.G.; Gijsen, A.P.; Kuipers, H.; Van Loon, L.J.C. Whey protein stimulates
postprandial muscle protein accretion more effectively than do casein and casein hydrolysate in older men.
Am. J. Clin. Nutr. 2011, 93, 997–1005. [CrossRef]
60. Mitchell, W.K.; Phillips, B.E.; Williams, J.P.; Rankin, D.; Lund, J.N.; Wilkinson, D.J.; Smith, K.; Atherton, P.J.
The impact of delivery profile of essential amino acids upon skeletal muscle protein synthesis in older men:
Clinical efficacy of pulse vs. bolus supply. Am. J. Physiol. Endocrinol. Metab. 2015, 309, E450–E457. [CrossRef]
61. Pennings, B.; Groen, B.B.L.; Van Dijk, J.W.; De Lange, A.; Kiskini, A.; Kuklinski, M.; Senden, J.M.G.;
Van Loon, L.J.C. Minced beef is more rapidly digested and absorbed than beef steak, resulting in greater
postprandial protein retention in older men. Am. J. Clin. Nutr. 2013, 98, 121–128. [CrossRef]
62. Barbé, F.; Ménard, O.; Gouar, Y.L.; Buffière, C.; Famelart, M.H.; Laroche, B.; Feunteun, S.L.; Rémond, D.;
Dupont, D. Acid and rennet gels exhibit strong differences in the kinetics of milk protein digestion and
amino acid bioavailability. Food Chem. 2014, 143, 1–8. [CrossRef] [PubMed]
63. Barbé, F.; Ménard, O.; Le Gouar, Y.; Buffière, C.; Famelart, M.H.; Laroche, B.; Le Feunteun, S.; Dupont, D.;
Rémond, D. The heat treatment and the gelation are strong determinants of the kinetics of milk proteins
digestion and of the peripheral availability of amino acids. Food Chem. 2013, 136, 1203–1212. [CrossRef]
[PubMed]
64. Rémond, D.; Machebeuf, M.; Yven, C.; Buffière, C.; Mioche, L.; Mosoni, L.; Mirand, P.P. Postprandial
whole-body protein metabolism after a meat meal is influenced by chewing efficiency in elderly subjects.
Am. J. Clin. Nutr. 2007, 85, 1286–1292. [CrossRef] [PubMed]
65. Bax, M.L.; Buffière, C.; Hafnaoui, N.; Gaudichon, C.; Savary-Auzeloux, I.; Dardevet, D.; Santé-Lhoutellier, V.;
Rémond, D. Effects of meat cooking, and of ingested amount, on protein digestion speed and entry of
residual proteins into the colon: A study in minipigs. PLoS ONE 2013, 8. [CrossRef]
66. Alemán-Mateo, H.; Carreón, V.R.; Macías, L.; Astiazaran-García, H.; Gallegos-Aguilar, A.C.; Enríquez, J.R.R.
Nutrient-rich dairy proteins improve appendicular skeletal muscle mass and physical performance, And
attenuate the loss of muscle strength in older men and women subjects: A single-blind randomized clinical
trial. Clin. Interv. Aging 2014, 9, 1517–1525. [CrossRef]
67. Zhu, K.; Kerr, D.A.; Meng, X.; Devine, A.; Solah, V.; Binns, C.W.; Prince, R.L. Two-year whey protein
supplementation did not enhance muscle mass and physical function in well-nourished healthy older
postmenopausal women. J. Nutr. 2015, 145, 2520–2526. [CrossRef]
68. Pennings, B.; Koopman, R.; Beelen, M.; Senden, J.M.G.; Saris, W.H.M.; Van Loon, L.J.C. Exercising before
protein intake allows for greater use of dietary protein-derived amino acids for de novo muscle protein
synthesis in both young and elderly men. Am. J. Clin. Nutr. 2011, 93, 322–331. [CrossRef]
69. Boirie, Y.; Dangin, M.; Gachon, P.; Vasson, M.P.; Maubois, J.L.; Beaufrère, B. Slow and fast dietary proteins
differently modulate postprandial protein accretion. Proc. Natl. Acad. Sci. USA 1997, 94, 14930–14935.
[CrossRef]
70. Reitelseder, S.; Agergaard, J.; Doessing, S.; Helmark, I.C.; Lund, P.; Kristensen, N.B.; Frystyk, J.; Flyvbjerg, A.;
Schjerling, P.; Van Hall, G.; et al. Whey and casein labeled with L-[1-13C]leucine and muscle protein synthesis:
Effect of resistance exercise and protein ingestion. Am. J. Physiol. Endocrinol. Metab. 2011, 300, E231–E242.
[CrossRef]
71. Yang, Y.; Breen, L.; Burd, N.A.; Hector, A.J.; Churchward-Venne, T.A.; Josse, A.R.; Tarnopolsky, M.A.;
Phillips, S.M. Resistance exercise enhances myofibrillar protein synthesis with graded intakes of whey
protein in older men. Br. J. Nutr. 2012, 108, 1780–1788. [CrossRef] [PubMed]
Nutrients 2020, 12, 2670 31 of 35
72. Robinson, M.J.; Burd, N.A.; Breen, L.; Rerecich, T.; Yang, Y.; Hector, A.J.; Baker, S.K.; Phillips, S.M.
Dose-dependent responses of myofibrillar protein synthesis with beef ingestion are enhanced with resistance
exercise in middle-aged men. Appl. Physiol. Nutr. Metab. 2013, 38, 120–125. [CrossRef] [PubMed]
73. Luiking, Y.C.; Deutz, N.E.P.; Memelink, R.G.; Verlaan, S.; Wolfe, R.R. Postprandial muscle protein synthesis
is higher after a high whey protein, leucine-enriched supplement than after a dairy-like product in healthy
older people: A randomized controlled trial. Nutr. J. 2014, 13. [CrossRef] [PubMed]
74. Farnfield, M.M.; Breen, L.; Carey, K.A.; Garnham, A.; Cameron-Smith, D. Activation of mTOR signalling
in young and old human skeletal muscle in response to combined resistance exercise and whey protein
ingestion. Appl. Physiol. Nutr. Metab. 2012, 37, 21–30. [CrossRef] [PubMed]
75. Chalé, A.; Cloutier, G.J.; Hau, C.; Phillips, E.M.; Dallal, G.E.; Fielding, R.A. Efficacy of whey protein
supplementation on resistance exercise-induced changes in lean mass, muscle strength, and physical function
in mobility-limited older adults. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2013, 68, 682–690. [CrossRef]
76. Kang, L.; Gao, Y.; Liu, X.; Liang, Y.Y.; Chen, Y.; Liang, Y.Y.; Zhang, L.; Chen, W.; Pang, H.; Peng, L.N. Effects
of whey protein nutritional supplement on muscle function among community-dwelling frail older people:
A multicenter study in China. Arch. Gerontol. Geriatr. 2019, 83, 7–12. [CrossRef]
77. Oikawa, S.Y.; McGlory, C.; D’Souza, L.K.; Morgan, A.K.; Saddler, N.I.; Baker, S.K.; Parise, G.; Phillips, S.M.
A randomized controlled trial of the impact of protein supplementation on leg lean mass and integrated
muscle protein synthesis during inactivity and energy restriction in older persons. Am. J. Clin. Nutr. 2018,
108, 1060–1068. [CrossRef]
78. Mojtahedi, M.C.; Thorpe, M.P.; Karampinos, D.C.; Johnson, C.L.; Layman, D.K.; Georgiadis, J.G.; Evans, E.M.
The effects of a higher protein intake during energy restriction on changes in body composition and physical
function in older women. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2011, 66A, 1218–1225. [CrossRef]
79. Weigle, D.S.; Breen, P.A.; Matthys, C.C.; Callahan, H.S.; Meeuws, K.E.; Burden, V.R.; Purnell, J.Q. A
high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite
compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am. J. Clin. Nutr. 2005, 82,
41–48. [CrossRef]
80. Coker, R.H.; Miller, S.; Schutzler, S.; Deutz, N.; Wolfe, R.R. Whey protein and essential amino acids promote
the reduction of adipose tissue and increased muscle protein synthesis during caloric restriction-induced
weight loss in elderly, obese individuals. Nutr. J. 2012, 11. [CrossRef]
81. Haub, M.D.; Wells, A.M.; Tarnopolsky, M.A.; Campbell, W.W. Effect of protein source on
resistive-training-induced changes in body composition and muscle size in older men. Am. J. Clin. Nutr.
2002, 76, 511–517. [CrossRef]
82. Durosier-Izart, C.; Biver, E.; Merminod, F.; Van Rietbergen, B.; Chevalley, T.; Herrmann, F.R.; Ferrari, S.L.;
Rizzoli, R. Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in
healthy postmenopausal women. Am. J. Clin. Nutr. 2017, 105, 513–525. [CrossRef] [PubMed]
83. Pistoia, W.; Van Rietbergen, B.; Lochmüller, E.M.; Lill, C.A.; Eckstein, F.; Rüegsegger, P. Estimation of
distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral
quantitative computed tomography images. Bone 2002, 30, 842–848. [CrossRef]
84. Frassetto, L.; Banerjee, T.; Powe, N.; Sebastian, A. Acid balance, dietary acid load, and bone effects—A
controversial subject. Nutrients 2018, 10, 517. [CrossRef] [PubMed]
85. Kerstetter, J.E.; Kenny, A.M.; Insogna, K.L. Dietary protein and skeletal health: A review of recent human
research. Curr. Opin. Lipidol. 2011, 22, 16–20. [CrossRef]
86. Hannan, M.T.; Tucker, K.L.; Dawson-Hughes, B.; Cupples, L.A.; Felson, D.T.; Kiel, D.P. Effect of dietary
protein on bone loss in elderly men and women: The framingham osteoporosis study. J. Bone Miner. Res.
2000, 15, 2504–2512. [CrossRef] [PubMed]
87. Roughead, Z.K. (Fariba); Johnson, L.K.; Lykken, G.I.; Hunt, J.R. Controlled High Meat Diets Do Not Affect
Calcium Retention or Indices of Bone Status in Healthy Postmenopausal Women. J. Nutr. 2003, 133, 1020–1026.
[CrossRef]
88. Cao, J.J.; Johnson, L.K.; Hunt, J.R. A diet high in meat protein and potential renal acid load increases fractional
calcium absorption and urinary calcium excretion without affecting markers of bone resorption or formation
in postmenopausal women. J. Nutr. 2011, 141, 391–397. [CrossRef]
Nutrients 2020, 12, 2670 32 of 35
89. Ballard, T.L.P.; Clapper, J.A.; Specker, B.L.; Binkley, T.L.; Vukovich, M.D. Effect of protein supplementation
during a 6-mo strength and conditioning program on insulin-like growth factor I and markers of bone
turnover in young adults. Am. J. Clin. Nutr. 2005, 81, 1442–1448. [CrossRef]
90. Mullins, N.M.; Sinning, W.E. Effects of resistance training and protein supplementation on bone turnover in
young adult women. Nutr. Metab. 2005, 2. [CrossRef]
91. Holm, L.; Olesen, J.L.; Matsumoto, K.; Doi, T.; Mizuno, M.; Alsted, T.J.; Mackey, A.L.; Schwarz, P.; Kjær, M.
Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass,
strength, and bone formation in postmenopausal women. J. Appl. Physiol. 2008, 105, 274–281. [CrossRef]
[PubMed]
92. Wright, C.S.; McMorrow, A.M.; Weinheimer-Haus, E.M.; Campbell, W.W. Whey protein supplementation
and higher total protein intake do not influence bone quantity in overweight and obese adults following a
36-week exercise and diet intervention. J. Nutr. 2017, 147, 179–186. [CrossRef] [PubMed]
93. Farnsworth, E.; Luscombe, N.D.; Noakes, M.; Wittert, G.; Argyiou, E.; Clifton, P.M. Effect of a high-protein,
energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and
obese hyperinsulinemic men and women. Am. J. Clin. Nutr. 2003, 78, 31–39. [CrossRef] [PubMed]
94. Josse, A.R.; Atkinson, S.A.; Tarnopolsky, M.A.; Phillips, S.M. Diets higher in dairy foods and dietary protein
support bone health during diet- and exercise-induced weight loss in overweight and obese premenopausal
women. J. Clin. Endocrinol. Metab. 2012, 97, 251–260. [CrossRef] [PubMed]
95. Houston, D.K.; Nicklas, B.J.; Ding, J.; Harris, T.B.; Tylavsky, F.A.; Newman, A.B.; Jung, S.L.; Sahyoun, N.R.;
Visser, M.; Kritchevsky, S.B. Dietary protein intake is associated with lean mass change in older,
community-dwelling adults: The health, aging, and body composition (health ABC) study. Am. J.
Clin. Nutr. 2008, 87, 150–155. [CrossRef] [PubMed]
96. Sahni, S.; Mangano, K.M.; Hannan, M.T.; Kiel, D.P.; McLean, R.R. Higher protein intake is associated with
higher lean mass and quadriceps muscle strength in adult men and women. J. Nutr. 2015, 145, 1569–1575.
[CrossRef] [PubMed]
97. Tang, J.E.; Moore, D.R.; Kujbida, G.W.; Tarnopolsky, M.A.; Phillips, S.M. Ingestion of whey hydrolysate,
casein, or soy protein isolate: Effects on mixed muscle protein synthesis at rest and following resistance
exercise in young men. J. Appl. Physiol. 2009, 107, 987–992. [CrossRef]
98. Phillips, S.M. A brief review of critical processes in exercise-induced muscular hypertrophy. Sport Med. 2014,
44, 71–77. [CrossRef]
99. Gorissen, S.H.; Horstman, A.M.; Franssen, R.; Crombag, J.J.; Langer, H.; Bierau, J.; Respondek, F.; van Loon, L.J.
Ingestion of wheat protein increases in vivo muscle protein synthesis rates in healthy older men in a
randomized trial. J. Nutr. 2016, 146, 1651–1659. [CrossRef]
100. Payette, H.; Gray-Donald, K.; Cyr, R.; Boutier, V. Predictors of dietary intake in a functionally dependent
elderly population in the community. Am. J. Public Health 1995, 85, 677–683. [CrossRef]
101. Benelam, B. Satiety and the anorexia of ageing. Br. J. Community Nurs. 2009, 14, 332–335. [CrossRef]
[PubMed]
102. Oikawa, S.Y.; Bahniwal, R.; Holloway, T.M.; Lim, C.; McLeod, J.C.; McGlory, C.; Baker, S.K.; Phillips, S.M.
Potato protein isolate stimulates muscle protein synthesis at rest and with resistance exercise in young
women. Nutrients 2020, 12, 1235. [CrossRef]
103. Wilkinson, S.B.; Tarnopolsky, M.A.; MacDonald, M.J.; MacDonald, J.R.; Armstrong, D.; Phillips, S.M.
Consumption of fluid skim milk promotes greater muscle protein accretion after resistance exercise than
does consumption of an isonitrogenous and isoenergetic soy-protein beverage. Am. J. Clin. Nutr. 2007, 85,
1031–1040. [CrossRef] [PubMed]
104. Candow, D.G.; Burke, N.C.; Smith-Palmer, T.; Burke, D.G. Effect of whey and soy protein supplementation
combined with resistance training in young adults. Int. J. Sport Nutr. Exerc. Metab. 2006, 16, 233–244.
[CrossRef] [PubMed]
105. DeNysschen, C.A.; Burton, H.W.; Horvath, P.J.; Leddy, J.J.; Browne, R.W. Resistance training with soy vs whey
protein supplements in hyperlipidemic males. J. Int. Soc. Sports Nutr. 2009, 6, 1–9. [CrossRef] [PubMed]
Nutrients 2020, 12, 2670 33 of 35
106. Hartman, J.W.; Tang, J.E.; Wilkinson, S.B.; Tarnopolsky, M.A.; Lawrence, R.L.; Fullerton, A.V.; Phillips, S.M.
Consumption of fat-free fluid milk after resistance exercise promotes greater lean mass accretion than does
consumption of soy or carbohydrate in young, novice, male weightlifters. Am. J. Clin. Nutr. 2007, 86, 373–381.
[CrossRef]
107. Babault, N.; Païzis, C.; Deley, G.; Guérin-Deremaux, L.; Saniez, M.-H.; Lefranc-Millot, C.; Allaert, F.A.
Pea proteins oral supplementation promotes muscle thickness gains during resistance training: A
double-blind, randomized, Placebo-controlled clinical trial vs. Whey protein. J. Int. Soc. Sports Nutr.
2015, 12, 3. [CrossRef]
108. Luiking, Y.C.; Engelen, M.P.K.J.; Soeters, P.B.; Boirie, Y.; Deutz, N.E.P. Differential metabolic effects of casein
and soy protein meals on skeletal muscle in healthy volunteers. Clin. Nutr. 2011, 30, 65–72. [CrossRef]
109. Deibert, P.; Solleder, F.; König, D.; Vitolins, M.Z.; Dickhuth, H.H.; Gollhofer, A.; Berg, A. Soy protein based
supplementation supports metabolic effects of resistance training in previously untrained middle aged males.
Aging Male 2011, 14, 273–279. [CrossRef]
110. Gilbert, J.A.; Bendsen, N.T.; Tremblay, A.; Astrup, A. Effect of proteins from different sources on body
composition. Nutr. Metab. Cardiovasc. Dis. 2011, 21, B16–B31. [CrossRef]
111. Shams-White, M.M.; Chung, M.; Fu, Z.; Insogna, K.L.; Karlsen, M.C.; LeBoff, M.S.; Shapses, S.A.; Sackey, J.;
Shi, J.; Wallace, T.C.; et al. Animal versus plant protein and adult bone health: A systematic review and
meta-analysis from the National Osteoporosis Foundation. PLoS ONE 2018, 13, e0192459. [CrossRef]
[PubMed]
112. Langsetmo, L.; Barr, S.I.; Berger, C.; Kreiger, N.; Rahme, E.; Adachi, J.D.; Papaioannou, A.; Kaiser, S.M.;
Prior, J.C.; Hanley, D.A.; et al. Associations of protein intake and protein source with bone mineral density
and fracture risk: A population-based cohort study. J. Nutr. Heal Aging 2015, 19, 861–868. [CrossRef]
[PubMed]
113. Lauderdale, D.S.; Jacobsen, S.J.; Furner, S.E.; Levy, P.S.; Brody, J.A.; Goldberg, J. Hip fracture incidence among
elderly Asian-American populations. Am. J. Epidemiol. 1997, 146, 502–509. [CrossRef]
114. Ma, D.F.; Qin, L.Q.; Wang, P.Y.; Katoh, R. Soy isoflavone intake inhibits bone resorption and stimulates bone
formation in menopausal women: Meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 2008, 62,
155–161. [CrossRef] [PubMed]
115. Pawlowski, J.W.; Martin, B.R.; McCabe, G.P.; McCabe, L.; Jackson, G.S.; Peacock, M.; Barnes, S.; Weaver, C.M.
Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in
postmenopausal women: A randomized crossover trial. Am. J. Clin. Nutr. 2015, 102, 695–703. [CrossRef]
[PubMed]
116. Alekel, D.L.; St. Germain, A.; Peterson, C.T.; Hanson, K.B.; Stewart, J.W.; Toda, T. Isoflavone-rich soy protein
isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 2000, 72,
844–852. [CrossRef]
117. Brink, E.; Coxam, V.; Robins, S.; Wahala, K.; Cassidy, A.; Branca, F. Long-term consumption of
isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status
in early postmenopausal women: A randomized, double-blind, placebo controlled study. Am. J. Clin. Nutr.
2008, 87, 761–770. [CrossRef]
118. Lee, H.; Choue, R.; Lim, H. Effect of soy isoflavones supplement on climacteric symptoms, bone biomarkers,
and quality of life in Korean postmenopausal women: A randomized clinical trial. Nutr. Res. Pract. 2017, 11,
223–231. [CrossRef]
119. Kreijkamp-Kaspers, S.; Kok, L.; Grobbee, D.E.; de Haan, E.H.F.; Aleman, A.; Lampe, J.W.; van der Schouw, Y.T.
Effect of Soy Protein Containing Isoflavones on Cognitive Function, Bone Mineral Density, and Plasma
Lipids in Postmenopausal WomenA Randomized Controlled Trial. JAMA 2004, 292, 65–74. [CrossRef]
120. Liu, Z.M.; Ho, S.C.; Chen, Y.M.; Ho, Y.P. A mild favorable effect of soy protein with isoflavones on body
compositiona 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal
women. Int. J. Obes. 2010, 34, 309–318. [CrossRef]
121. Chiang, T.I.; Chang, I.C.; Lee, H.H.; Hsieh, K.H.; Chiu, Y.W.; Lai, T.J.; Liu, J.Y.; Hsu, L.S.; Kao, S.H.
Amelioration of estrogen deficiency-induced obesity by collagen hydrolysate. Int. J. Med. Sci. 2016, 13,
853–857. [CrossRef] [PubMed]
Nutrients 2020, 12, 2670 34 of 35
122. Kitakaze, T.; Sakamoto, T.; Kitano, T.; Inoue, N.; Sugihara, F.; Harada, N.; Yamaji, R. The collagen derived
dipeptide hydroxyprolyl-glycine promotes C2C12 myoblast differentiation and myotube hypertrophy.
Biochem. Biophys. Res. Commun. 2016, 478, 1292–1297. [CrossRef]
123. Phillips, S.M. The impact of protein quality on the promotion of resistance exercise-induced changes in
muscle mass. Nutr. Metab. 2016, 13, 1–9. [CrossRef] [PubMed]
124. Caldow, M.K.; Ham, D.J.; Trieu, J.; Chung, J.D.; Lynch, G.S.; Koopman, R. Glycine protects muscle cells from
wasting in vitro via mTORC1 signaling. Front. Nutr. 2019, 6, 1–7. [CrossRef] [PubMed]
125. Okiura, T.; Oishi, Y.; Takemura, A.; Ishihara, A. Effects of collagen hydrolysate on the tibialis anterior muscle
and femur in senescence-accelerated mouse prone 6. J. Musculoskelet. Neuronal Interact. 2016, 16, 161–167.
[PubMed]
126. Shaw, G.; Lee-Barthel, A.; Ross, M.L.; Wang, B.; Baar, K. Vitamin C-enriched gelatin supplementation before
intermittent activity augments collagen synthesis. Am. J. Clin. Nutr. 2017, 105, 136–143. [CrossRef] [PubMed]
127. Hays, N.P.; Kim, H.; Wells, A.M.; Kajkenova, O.; Evans, W.J. Effects of whey and fortified collagen hydrolysate
protein supplements on nitrogen balance and body composition in older women. J. Am. Diet. Assoc. 2009,
109, 1082–1087. [CrossRef] [PubMed]
128. Kirmse, M.; Oertzen-Hagemann, V.; de Marées, M.; Bloch, W.; Platen, P. Prolonged collagen peptide
supplementation and resistance exercise training affects body composition in recreationally active men.
Nutrients 2019, 11, 1154. [CrossRef]
129. Impey, S.G.; Hammond, K.M.; Naughton, R.; Langan-Evans, C.; Shepherd, S.O.; Sharples, A.P.; Cegielski, J.;
Smith, K.; Jeromson, S.; Hamilton, D.L.; et al. Whey protein augments leucinemia and postexercise p70s6k1
activity compared with a hydrolyzed collagen blend when in recovery from training with low carbohydrate
availability. Int. J. Sport Nutr. Exerc. Metab. 2018, 28, 651–659. [CrossRef]
130. Oikawa, S.Y.; Macinnis, M.J.; Tripp, T.R.; Mcglory, C.; Baker, S.K.; Phillips, S.M. Lactalbumin, not collagen,
augments muscle protein synthesis with aerobic exercise. Med. Sci. Sport Exerc. 2020, 52. [CrossRef]
131. Kjær, M.; Magnusson, P.; Krogsgaard, M.; Møller, J.B.; Olesen, J.; Heinemeier, K.; Hansen, M.; Haraldsson, B.;
Koskinen, S.; Esmarck, B.; et al. Extracellular matrix adaptation of tendon and skeletal muscle to exercise.
J. Anat. 2006, 208, 445–450. [CrossRef]
132. Rindom, E.; Nielsen, M.H.; Kececi, K.; Jensen, M.E.; Vissing, K.; Farup, J. Effect of protein quality on recovery
after intense resistance training. Eur. J. Appl. Physiol. 2016, 116, 2225–2236. [CrossRef] [PubMed]
133. Lewis, M.I.; Fournier, M.; Storer, T.W.; Bhasin, S.; Porszasz, J.; Ren, S.G.; Da, X.; Casaburi, R. Skeletal muscle
adaptations to testosterone and resistance training in men with COPD. J. Appl. Physiol. 2007, 103, 1299–1310.
[CrossRef]
134. Phillips, S.M.; Tipton, K.D.; Van Loon, L.J.C.; Verdijk, L.B.; Paddon-Jones, D.; Close, G.L. Exceptional
body composition changes attributed to collagen peptide supplementation and resistance training in older
sarcopenic men. Br. J. Nutr. 2016, 116, 569–570. [CrossRef] [PubMed]
135. Jendricke, P.; Centner, C.; Zdzieblik, D.; Gollhofer, A.; König, D. Specific collagen peptides in combination
with resistance training improve body composition and regional muscle strength in premenopausal women:
A randomized controlled trial. Nutrients 2019, 11, 892. [CrossRef] [PubMed]
136. Vechin, F.C.; Libardi, C.A.; Conceição, M.S.; Damas, F.; Cavaglieri, C.R.; Chacon-Mikahil, M.P.T.;
Coutinho, L.L.; Andrade, S.C.S.; Neves, M.T.; Roschel, H.; et al. Low-intensity resistance training with
partial blood flow restriction and high-intensity resistance training induce similar changes in skeletal muscle
transcriptome in elderly humans. Appl. Physiol. Nutr. Metab. 2019, 44, 216–220. [CrossRef] [PubMed]
137. Centner, C.; Zdzieblik, D.; Roberts, L.; Gollhofer, A.; König, D. Effects of blood flow restriction training with
protein supplementation on muscle mass and strength in older men. J. Sport Sci. Med. 2019, 18, 471–478.
138. Guillerminet, F.; Beaupied, H.; Fabien-Soulé, V.; Tomé, D.; Benhamou, C.L.; Roux, C.; Blais, A. Hydrolyzed
collagen improves bone metabolism and biomechanical parameters in ovariectomized mice: An in vitro and
in vivo study. Bone 2010, 46, 827–834. [CrossRef]
139. Han, X.L.; Xu, Y.J.; Wang, J.B.; Pei, X.R.; Yang, R.Y.; Li, N.; Li, Y. Effects of cod bone gelatin on bone metabolism
and bone microarchitecture in ovariectomized rats. Bone 2009, 44, 942–947. [CrossRef]
140. Elam, M.L.; Johnson, S.A.; Hooshmand, S.; Feresin, R.G.; Payton, M.E.; Gu, J.; Arjmandi, B.H.
A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with
osteopenia: A randomized controlled trial. J. Med. Food 2015, 18, 324–331. [CrossRef]
Nutrients 2020, 12, 2670 35 of 35
141. König, D.; Oesser, S.; Scharla, S.; Zdzieblik, D.; Gollhofer, A. Specific collagen peptides improve bone mineral
density and bone markers in postmenopausal women—A randomized controlled study. Nutrients 2018,
10, 97. [CrossRef] [PubMed]
142. Pinnell, S.R. Regulation of collagen biosynthesis by ascorbic acid: A review. Yale J. Biol. Med. 1985, 58,
553–559. [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
